1. No category

PSORIASIS
FROM GENE TO CLINIC
7th International Congress
The Royal College of Physicians, London, UK
11th-13th December 2014
Organised by Conference and Events Services
of The British Association of Dermatologists
under the auspices of St. John’s Institute of Dermatology,
Kings College London and the Dermatology Centre,
University of Manchester
Please put the date in your diary!
CO-ORGANISERS
Jonathan Barker London, UK
Christopher Griffiths Manchester, UK
SCIENTIFIC COMMITTEE
Hervé Bachelez Paris, France
James Elder Ann Arbor, USA
Alexa Kimball Boston, USA
James Krueger New York, USA
Alan Menter Dallas, USA
Frank Nestle London, UK
Errol Prens Rotterdam, The Netherlands
Jörg Prinz Munich, Germany
Peter Van de Kerkhof Nijmegen, The Netherlands
PROGRAMME
The programme will concentrate on key issues relating
to psoriasis at both scientific and clinical levels.
There will be keynote and invited lecturers present.
Plenary sessions will cover the following topics:
• Genetics
• Immunology and immunity
• Co-morbidities and outcome measures
• Targeted therapeutics
For further information please contact:
Organising Secretariat
Conference and Event Services
British Association of Dermatologists
4 Fitzroy Square, London W1T 5HQ
Tel: +44 (0)20 7391 6358 Fax: +44 (0)20 7388 0487
Email: conference@bad.org.uk
Website: www.psoriasisg2c.com
Index
Wednesday 2nd July Overview
Overview
28
Plenary session – Understanding Pharma
31
Badges
7
Plenary session - Medical Dermatology
39
Banking
7
BAD and BDNG Joint Mee ng
42
Business Services
7
Historical
32
Catering
7
Commonwealth Session
33
Cer ficates of a endance
7
Bri sh Teledermatology Society (BTS)
34
Cloakroom
7
Public Lecture
35
Commi ee mee ngs
11
Bri sh Society for Paediatric Dermatology (BSPD)
40-41
Con nuing Professional Development (CPD)
7
Exhibi on
7
Thursday 3rd July Overview
43
Exhibi on quiz
7
Plenary Session Professors & Registrars forum
44
Exhibi on Plan
53
CPD update
48
Focus Sessions
49
Bri sh Photodermatology Group (BPG)
Bri sh Society for Skin Care In Immunocompromised
45
Individuals (BSSCII)
46-47
First aid
7
Focus Sessions
49
Hot Topics Overview
52
Map of Glasgow
54
Mee ngs Calendar
55
Keynote Lectures
Organising Commi ees
4
Parking
7
Pa ent support groups
53
Tuesday
Professor Amrinder J Kanwar
Professor Robert Moots
26
26
Payment of registra on fees
7
Poster exhibi on
7
Wednesday
Professor Sir Ian Kennedy
31
Posters
50-51
Programme Overview
6
Thursday
Dr Rachael Clark
Professor Vinod Sharma
48
48
Registra on desk
7
Satellite Symposia
7
Social events
10
Speaker preview
7
Transport - to and from Glasgow
7
Venue Plan
8-9
Welcome to Glasgow
5
Monday 30th June Overview
12
Trainee pre-conference session
14
SAS Session
15
BSD Self-Assessment
13
Tuesday 1st July Overview
16
CPCs - Joint BAD / BSD
17
Bri sh Society of Cutaneous Allergy (BSCA)
18
Bri sh Society for Dermatological Surgery (BSDS)
20-22
Bri sh Society for Dermatopathology (BSD)
24-25
Plenary Session – Submi ed papers
26
BADGEM
19
Senior Skin Group
23
Dermatology Teachers
27
3
Overview
58
App
Overview
CONFERENCE & EVENT SERVICES
BSD ABSTRACT SELECTION COMMITTEE
Mr Chris Garre - Conference & Event Services Manager
Mrs Jenna Bowler – Senior Events Coordinator
Mrs Marie Elwér – Finance and Conference Administrator
Miss Sally-Ann Koomson – Marke ng & Events Coordinator
Miss Sophie Jackson – Events Coordinator
Dr Thomas Brenn
Dr Eduardo Calonje
Dr Paul Craig
Dr Manuraj Singh
BSDS & BCDG ABSTRACT SELECTION
COMMITTEE
ORGANISING COMMITTEE
Dr Khadija Al Jefri
Miss Marilyn Benham
Mrs Jenna Bowler
Dr David Brass
Prof Chris Bunker
Dr David J Eedy
Mr Chris Garre
Mrs Catherine Hanaway
Prof Eugene Healy
Dr Glenda Hill
Prof Irene Leigh
Dr Anshoo Sahota
Dr Graham Sharpe - Chair
Dr Chris Bower
Dr Vindy Ghura
Dr Wal Hussain
Dr Stephen Keohane
Dr Nick Lowe
BSSCII ABSTRACT SELECTION COMMITTEE
Prof Catherine Harwood
Dr John Lear
Dr David Paige
Dr William Phillips
Prof Charlo e Proby
Dr Helen Ramsay
BAD ABSTRACT SELECTION COMMITTEE
BTS ABSTRACT SELECTION COMMITTEE
Dr Thomas Brenn
Prof Eugene Healy
Dr Eduardo Calonje
Dr Paul Craig
Dr Walayat Hussain
Prof Irene Leigh
Dr Catherine Orteu
Dr Manuraj Singh
Dr Helen Young
Dr Carolyn Charman
Dr David de Berker
Dr Saul Halpern
Dr Andy MacFarlane
Dr Colin Morton
DERMATOLOGY TEACHERS SELECTION
COMMITTEE
Dr Stuart Cohen
Dr Shaheen Haque
Dr Jon Goulding
Dr Gayathri Perera
Dr Minal Singh
BAD JUDGING COMMITTEE
Dr Catherine Orteu - Chair
BPG ABSTRACT SELECTION COMMITTEE
HISTORICAL ABSTRACT SELECTION
Dr Richard Dawe
Dr Chris Edwards
Dr Hiva Fassihi
Prof James Ferguson
Dr Victoria Goulden
Dr Ljubomir Novakovic
Dr Robert Sarkany
Dr Peter Copeman
Dr David Eedy
Dr Julia Ellis
Dr Frances Humphreys
Dr Nick Levell
Dr Sid Orpin
Dr Rakesh Patalay
Dr Paul Yesudian
BSCA ABSTRACT SELECTION COMMITTEE
Dr Donna Thompson
Dr Sarah Wakelin
Dr Mark Wilkinson
BSPD ABSTRACT SELECTION COMMITTEE
Dr Paula Bea e
Dr Fiona Browne
Dr Jane Ravenscro
ACKNOWLEDGEMENTS
The Bri sh Associa on of Dermatologists gratefully acknowledges the contribu on of the many
exhibitors & sponsors whose a endance has helped make the mee ng possible.
4
A Warm Welcome to Glasgow 2014
he 94th Annual Mee ng of the Bri sh Associa on of Dermatologists will see us return to the
city of Glasgow, the venue for the 2009 mee ng. Once again we will be in the award winning
Sco sh Exhibi on & Conven on Centre.
Glasgow is a city with everything to offer. It is Scotland’s cultural capital and one of the most
dynamic ci es in Europe: steeped in culture, rich in history, with elegant streets, squares, parks and
gardens; the name Glasgow actually means ‘dear green place’. What’s more, it’s one of the UK’s
finest Victorian ci es with magnificent architecture everywhere you look. The respected Lonely
Planet guide recently said of the city: “Glasgow is regenera ng and evolving at a dizzying pace. Its
Victorian architectural legacy is now swamped with cu ng-edge style bars and world-class venues
to ckle your taste buds. The city is going through a long-term transforma on, evident along the
revitalised River Clyde.”
SCIENTIFIC PROGRAMME
Building on its reputa on as a high quality interna onally renowned event, the BAD is delighted to announce the Annual Mee ng
for 2014. The annual mee ng commi ee has again worked hard to provide a blend of new scien fic presenta ons with updates
from experts in various fields. We are pleased to announce that the Arthur Rook Ora on will be delivered by Dr Rachael Clark from
Boston, USA. Professor Robert Moots from Liverpool and Professor Amrinder Kanwar from India will give the first of the guest
lectures at the plenary session on Tuesday speaking on ‘ Behçet’s Syndrome: a new approach’ and ‘ Vi ligo-an Indian perspec ve’
respec vely. Wednesday’s programme features Professor Sir Ian Kennedy who will update the BAD membership on Professional
Regula on. The final guest lecture will come from Professor Vinod Sharma, who will talk during the CPD session on Thursday
a ernoon speaking on ‘Photodermatoses in pigmented skin’.
We will have a new Commonwealth session on Wednesday morning and following feedback from the 2013 evalua on we have
spread the Special Interest Groups to offer a be er balance to the three days. Please also look out for the new ‘Hot topics’ within
the Exhibi on Hall.
On Monday 30th June we will be holding pre-conference sessions for trainees, Specialty & Associate Specialist doctors, medical
students and there will be a BSD self assessment session.
Socially, the Annual Dinner will be at the Kelvingrove Museum on Wednesday evening, with a Welcome Recep on in the Glasgow
Science Centre on the Tuesday evening.
This year’s mee ng will have an Interna onal feel with a endees from India, Sri Lanka, Canada, USA and China.
We offer a warm welcome to all delegates and hope you enjoy the mee ng!
Dr Graham Sharpe
Clinical Vice President (2012-2014)
5
Overview
T
Programme Overview
Overview
MONDAY 30 JUNE 2014
TIME
SESSION DETAIL
ROOM
INFORMATION
12:15 – 18:00
Trainee Pre-conference Session
Lomond
Page 14
12:15 – 17:35
Speciality & Associate Specialist Session
Leven
Page 15
12:45 – 18:15
BSD Self-Assessment
Carron
Page 13
TUESDAY 1 JULY 2014
TIME
SESSION DETAIL
ROOM
INFORMATION
09:00 – 12:10
Clinicopathological Cases
Lomond
Page 17
08:30 – 12:45
Bri sh Society of Cutaneous Allergy
Boisdale
Page 18
09:00 – 13:00
BADGEM
Dochart 2
Page 19
10:45 – 11:15
Hot Topics
Exhibi on
Page 52
11:15 – 17:30
Bri sh Society for Dermatological Surgery
Alsh
Page 20-22
12:30 – 14:00
Senior Skin Group
Dochart 1
Page 23
14:00 – 14:15
Opening Address
Lomond
Page 26
14:00 – 17:30
Bri sh Society for Dermatopathology
Boisdale
Page 24-25
14:15 – 14:45
Guest Lecturer: Professor Amrinder J Kanwar
Lomond
Page 26
14:45 – 17:30
Plenary Session – Submi ed Papers
Lomond
Page 26
15:45 – 16:15
Hot Topics
Exhibi on
Page 52
16:30 – 17:30
Dermatology Teachers
Dochart 1
Page 27
17:30 – 18:00
Guest Lecturer: Professor Robert Moots
Lomond
Page 26
18:00 – 20:00
Welcome Recep on
Glasgow Science Centre
Page 10
WEDNESDAY 2 JULY 2014
TIME
SESSION DETAIL
ROOM
INFORMATION
08:00 – 08:45
Novar s Sponsored Symposium
Alsh
Page 29
08:00 – 08:45
Celgene Sponsored Symposium
Boisdale
Page 30
08:45 – 10:15
Plenary session – Understanding Pharma
Lomond
Page 31
08:45 – 10:45
Historical
Carron
Page 32
08:45 – 10:15
Commonwealth Session
Dochart
Page 33
08:45 – 10:15
Bri sh Teledermatology Society
Leven
Page 34
10:15 – 10:45
Guest Lecturer: Professor Sir Ian Kennedy
Lomond
Page 31
11:15 – 13:00
AGM – BAD members only
Lomond
11:30 – 12:30
Public Lecture
Alsh
Page 35
13:15 – 14:15
Novar s Sponsored Symposium
Boisdale
Page 36
13:15 – 14:15
Roche Sponsored Symposium
Carron
Page 37
13:15 – 14:15
Leo Pharma Sponsored Symposium
Dochart
Page 38
14:30 – 17:50
Plenary session - Medical Dermatology
Lomond
Page 39
14:30 – 18:00
Bri sh Society for Paediatric Dermatology
Alsh
Page 40-41
15:30 – 18:00
BAD and BDNG Joint Mee ng
Boisdale
Page 42
16:15 – 16:45
Hot Topics
Exhibi on
Page 52
19:30 – 00:00
Annual Dinner
Kelvingrove Museum
Page 10
INFORMATION
THURSDAY 3 JULY 2014
TIME
SESSION DETAIL
ROOM
07:45 – 08:45
Chris an Medical Fellowship Breakfast
Ness
08:45 – 12:40
Plenary Session Professors & Registrars forum
Lomond
Page 44
08:45 – 12:45
Bri sh Photodermatology Group
Alsh
Page 45
08:50 – 12:30
Bri sh Society for Skin Care in Immunocompromised Individuals
Carron
Page 46-47
13:30 – 14:15
Arthur Rook Ora on: Dr Rachael Clark
Lomond
Page 48
13:30 – 17:00
CPD update
Lomond
Page 48
14:15 – 17:00
Focus Session - Alopecia
Alsh
Page 49
15:00 – 15:30
Focus Session - Itch
Boisdale
Page 49
15:00 – 15:30
Focus Session - Hyperhidrosis
Carron
Page 49
6
A-Z
PAYMENT OF REGISTRATION FEES
We would prefer delegates to pay by cheque (pounds sterling drawn on
a UK bank only or by sterling bank draft) made payable to the ‘British
Association of Dermatologists’. Cheques in other currencies cannot be
accepted. Alternatively, delegates may pay by credit card and this is
encouraged for overseas delegates. Please note that we only accept
MasterCard and Visa. American Express cannot be accepted.
The app will provide the following features;
• Review agenda & speakers
• View sponsors & exhibitors
• Interactive floorplans
• Select sessions to record your
• View abstracts & e-posters
own CPD
POSTER EXHIBITION
BADGES
The poster exhibi on will be located within the exhibi on hall. The posters
will be numbered and a list is provided at the back of this programme.
Conference badges will be handed to delegates on registration. For
security purposes name badges must be worn at all times throughout the
meeting. In the event that you lose your badge, a replacement must be
obtained at the registration desk immediately.
There will be an e-poster display area showing all the posters submi ed.
Posters should be removed by 14:00 on Thursday 3rd July. Please note that
the Bri sh Associa on of Dermatologists cannot be held responsible for any
loss or damage to a poster presented during the Annual Mee ng.
BANKING
ATM facilities are available on the SECC complex.
REGISTRATION DESK
BUSINESS SERVICES
The registration desk will be located in the entrance to the exhibition and
will be staffed by the BAD team during the following hours:
The SECC has a well equipped Information & Business Centre for visitors.
Available services include:
PC Use/Internet Access
Scanning
Photocopying
Faxing
Printing
Gift Shop
Monday 30th June
Tuesday 1st - Thursday 3rd July
SATELLITE SYMPOSIA
CATERING
The following companies will be holding satellite symposia at the mee ng:
Wednesday 2nd July
08:00 – 08:45
Alsh
08:00 – 08:45
Boisdale
13:15 – 14:15
Boisdale
13:15 – 14:15
Dochart
13:15 – 14:15
Carron
Lunch and all scheduled refreshment breaks will be served from
designated points in the exhibition area, Hall 5 of the SECC.
Each lunch cket will en tle you to one choice of lunch offered at the various
catering pods. Addi onal lunch items can be purchased on a cash basis.
CERTIFICATE OF ATTENDANCE
Speaker preview will be located in the Etive in the Lomond Suite, please
ask at the registration desk for directions. All presenters must take
their memory sticks to speaker preview at least two hours prior to their
presentation. Data projection (PowerPoint) will be available.
CLOAKROOM
There is a cloakroom located on the main concourse. There is a charge of £2
per item. Guests will also be able to store luggage on the day of departure
TAXIS
CONTINUING PROFESSIONAL DEVELOPMENT
CREDITS (CPD)
There is a taxis rank pick-up and drop -off point at the East entrance
adjacent to the Clyde Auditorium.
This event is approved for external credit for the CPD scheme of the Federa on
of Royal Colleges of Physicians of the UK. Physicians should record their
credits in their diaries, in accordance with the current RCP recommenda ons.
Par cipants should only record the number of hours they a ended.
TRANSPORT – IN AND AROUND GLASGOW TO
AND FROM THE SECC
http://www.secc.co.uk/attend/how-to-get-here.aspx
EXHIBITION
Travelling to Glasgow by Train
Glasgow’s Central sta on is connected with every city in the UK. The
Exhibi on Centre sta on is the SECC’s own dedicated railway sta on allowing
easy access from the city centre and the suburbs. Six trains an hour (around
every 10 minutes) from Central sta on (Pla orm 17 is on the lower level) will
bring you to Exhibi on Centre sta on in a journey me of just three minutes.
The exhibition will be located in Hall 5 of the SECC and will be open at the
following times:
Thursday 3rd July:
Novartis
Celgene
Novartis
Leo Pharma
Roche
SPEAKER PREVIEW
Certificates of attendance will be in your registration envelope.
Tuesday 1st July:
10:00 – 17:30
Wednesday 2nd July: 08:30 – 17:30
09:00 – 18:00
08:00 – 18:00
08:30 – 14:00
Travelling to Glasgow by Plane
Glasgow’s interna onal airport is a 15 minute drive from SECC and provides
direct access to and from major European and North American ci es.
There are direct flights to Glasgow from London, Birmingham, Manchester,
Southampton, Bristol, Cardiff, East Midlands, Exeter and Leeds/Bradford.
EXHIBITION QUIZ
Exhibition quiz forms will be included in the delegate bags. To participate
in the quiz, delegates must visit each participating exhibitor and answer
a simple question. Participants must also obtain four answers from the
patient support groups, please note you only need four from any of the
patient support groups present over the duration of the meeting. All
completed quiz forms must be returned to the registration desk by 14:00
on Thursday 3rd July. The prizes will be announced after the meeting.
Travelling to Glasgow by Car
The SECC is just off junction 19 of the M8 motorway. For further details
please visit http://www.secc.co.uk/attend/how-to-get-here/car.aspx
FIRST AID
VENUE
The well equipped Medical Centre is located on the concourse of the
main building, at the East entrance.
Scottish Exhibition & Conference Centre (SECC)
Exhibition Way, Glasgow G3 8YW
PARKING
Tel: 0141 248 3000 Email: info@secc.co.uk www.secc.co.uk
The nearest car park to the SECC is the multi-storey car park operated
by City Parking (Glasgow) LLP. The car park is open 24 hours a day. The
facility is located at 10 Stobcross Road, Glasgow, G3 8YW.
Wi-Fi
There is Wi-Fi access throughout the SECC.
7
Overview
APP
We are pleased to announce that we will be providing a smartphone
conference app for delegates to use during the conference.
Overview
Venue Plan
8
Venue Plan
Overview
ESCALATOR
Clydebuilt
9
Overview
Social Events
WELCOME RECEPTION
1 July 2014, The Glasgow Science Centre
18:00 - 20:00
The Welcome Recep on will be held at
the Glasgow Science Centre, situated in
the heart of Glasgow on the banks of the
River Clyde. Striking with its tanium clad
structures; it features the Science Mall as
well as the IMAX theatre.
The centre aims to showcase Scotland’s
contribu on to science and technology,
past, present and future. The Glasgow
Science Centre is a five minute walk from
the SECC across the River Clyde.
Drinks and canapés will be served and all
registered delegates are invited to a end
the Welcome Recep on
ANNUAL DINNER
2 July 2014, Kelvingrove Art Gallery
and Museum
19:30 – 00:00
The Annual Dinner will be held at the
Kelvingrove Art Gallery and Museum,
a striking building in the beau ful
surroundings of Kelvingrove Park.
Kelvingrove Art Gallery and Museum
houses one of Europe’s great art
collec ons. It is amongst the top three
free to enter visitor a rac ons in Scotland
and one of the most visited museums in
the United Kingdom outside of London.
A Ceilidh – a Sco sh dance with a
tradi onal band will be held prior to the
disco. Learn new dance steps with help
from the band caller!
10
Commi ee Mee ngs
TIME
MEETING DETAIL
ROOM
10:30 – 16:00
BJD Editorial Team Mee ng
Ness
11:00 – 13:00
SAS Sub-commi ee
Fyne
14:00 – 16:00
Bri sh Associa on of Dermatologists Officers
Fyne
18:30 – 19:30
Na onal Dermatology Trainee Commi ee
Dochart 2
TUESDAY 1 JULY 2014
TIME
MEETING DETAIL
ROOM
08:00 – 09:00
Bri sh Society for Dermatopathology Exec Commi ee
Fyne
08:30 – 10:30
Bri sh Skin Founda on Grants Advisory
Morar
08:30 – 09:30
The Bri sh Society of Cutaneous Allergy (BSCA) AGM
Boisdale
09:30 – 10:30
BAD Finance Mee ng
Ness
11:15 – 13:00
Dermatology Industry Group
Morar
12:00 – 14:00
Community Dermatology Editorial Board Mee ng
Ness
13:00 – 14:00
Bri sh Cosme c Dermatology Group AGM
Carron 1
14:00 – 14:30
Bri sh Society for Dermatopathology AGM
Boisdale
14:00 – 15:30
Teachers of Undergraduate Dermatology
Leven
14:00 – 15:30
Health Informa cs Sub-commi ee
Morar
14:00 – 16:00
The Bri sh Society of Cutaneous Allergy Commi ee
Fyne
14:30 – 16:30
BADGEM Informa cs sub-group mee ng
Dochart 2
16:00 – 17:00
Therapy & Guidelines Sub-commi ee
Morar
17:05 – 17:30
Bri sh Society for Dermatological Surgery AGM
Alsh
WEDNESDAY 2 JULY 2014
TIME
MEETING DETAIL
ROOM
08:00 – 09:00
Skin Cancer Preven on Sub-commi ee mee ng
Ness
08:00 – 09:00
BJD Editorial Board Mee ng
Morar
09:30 – 11:00
Bri sh Society for Paediatric Dermatology Training Commi ee
Fyne
10:00 – 10:15
Bri sh Teledermatology Society AGM
Leven
10:45 – 11:15
Historical Collec on Sub-Commi ee
Carron
11:15 – 13:00
Bri sh Associa on of Dermatologists AGM (Members Only)
Lomond
13:00 – 14:00
Bri sh Associa on of Dermatologists Officers
Katrine
13:15 – 14:15
Bri sh Society for Paediatric Dermatology Commi ee
Morar
14:15 – 15:15
Bri sh Associa on of Dermatologists Execu ve Commi ee
Leven
14:30 – 17:30
Bri sh Society for Dermatological Surgery Commi ee
Ness
17:00 – 18:00
UK DCTN Trial Priori sa on Panel
Katrine
18:00 – 19:00
Bri sh Society for Medical Dermatology Commi ee
Ness
THURSDAY 3 JULY 2014
TIME
MEETING DETAIL
ROOM
08:30 – 09:30
Exhibitors’ Mee ng
Leven
11:30 – 13:00
UK Dermatology Clinical Trials Network AGM
Ness
12:05 – 12:30
Bri sh Society for Skin Care in Immunocompromised Individuals AGM
Carron
12:15 – 12:45
Bri sh Photodermatology Group AGM
Alsh
12:30 – 13:30
Bri sh Epidermo-Epidemiology Society AGM
Fyne
13:00 – 14:30
World Congress on Cancers of the Skin 2014 Programme Commi ee
Leven
14:30 – 15:30
World Congress on Cancers of the Skin 2014 LOC
Leven
15:00 – 16:30
Bri sh Photodermatology Group Commi ee
Katrine
11
Overview
MONDAY 30 JUNE 2014
Monday 30 June Overview
MONDAY 30 JUNE 2014
SESSION DETAIL
ROOM
INFORMATION
12:15 – 18:00
Trainee Pre-conference Session
Lomond
Page 14
12:15 – 17:35
Speciality & Associate Specialist Session
Leven
Page 15
12:45 – 18:15
BSD Self-Assessment
Carron
Page 13
Mon 30 June
TIME
12
2nd BSD Dermatopathology Self Assessment
Date:
Time:
Room:
Chair:
Monday 30th June
12:45-18:15
Carron
Dr Paul Craig
PROGRAMME
Lunch
15:45 – 16:15
Dochart 2 Room
Presentation of Cases 1 - 20
13:45 – 15:45
Break
Dochart 2 Room
16:15 – 18:15
Presentation of Cases 21 - 40
18:15
Evaluation forms, certificates and end of session
Royal College of Pathologists approved for CPD maximum of 6 credits
Speakers:
Chris Fletcher
Asok Biswas
Karen Blessing
Thomas Brenn
Eduardo Calonje
Rino Cerio
Paul Craig
Luisa Motta
Colin Moyes
Maureen Walsh
NOTES
13
Mon 30 June
12:45 – 13:45
Trainee Session
Date:
Time:
Room:
Chair:
Monday 30th June
12:15-18:00
Lomond
Dr Khadija Al-Jefri and Dr David de Berker
Mon 30 June
PROGRAMME
12:15 – 12:55
Lunch
Boisdale Room
Welcome and Introduction
Dr Khadija Al-Jefri and Dr David de Berker
12:55 – 13:00
13:00 – 13:30
TPC01
Allergy and Patch testing
Dr Jonathan White
13:30 – 14:00
TPC02
Skin surgery- common skin flaps
Dr Tom Oliphant
14:00 – 14:30
TPC03
Dermatology in the immunocompromised
Prof Charlotte Proby
14:30 – 15:00
TPC04
Cases from the Paediatric Dermatology Clinic
Dr Hossain Shahidullah
15:00 – 15:30
TPC05
Topical photodynamic therapy in dermatology
Dr Sally Ibbotson
15:30 – 15:40
TPC06
Update on trainee issues
Dr Khadija Aljefri
15:40 – 16:00
Break
Boisdale Room
16:00 – 16:30
TPC07
Medicolegal cases in dermatology/Medicolegal guidance
Dr Jane McGregor
16:30 – 17:00
TPC08
Introduction to teledermatology
Dr David de Berker
17:00 – 17:30
TPC09
Vulval dermatoses
Dr Janet McLelland
17:30 – 18:00
TPC10
Porter’s Penile Pearls
Dr Bill Porter
18:00
TPC11
Quiz
18:00 – 21:00
Trainee evening event @ Clyde Built
NOTES
14
Speciality & Associate Specialists Session
Date:
Time:
Room:
Chair:
Monday 30th June
12:15-17:35
Leven
Dr Inma Mauri-Sole
PROGRAMME
Lunch
Morar Room
Welcome and Introduction
Dr Glenda Hill
13:00 – 13:05
13:05 – 13:45
SAS01
All you need to know to manage Darier’s & Hailey-Hailey Disease
Dr Ruth Murphy
13:45 – 14:25
SAS02
Assessment & categorisation of skin wounds-how I manage them
Dr Catriona Wootton
14:25 – 15:05
SAS03
Recent developments in Neurofibromatosis relevant to dermatology
Dr Emma Burkitt-Wright
15:05 – 15:35
Break
Morar Room
15:35 – 16:15
SAS04
Lumps & Bumps in Paediatric dermatology-safe or scary?
Dr Olivia Schofield
16:15 – 16:55
SAS05
Graft vs Host Disease- focusing on cutaneous manifestations
Dr Fiona Child
16:55 – 17:35
SAS06
Isolated limb perfusion or ECT for malignant Melanoma-an overview
Dr Jerry Marsden
17:35
Closing Remarks
19:30 – 22:00
SAS evening event @ La Rotunda (pre-booked only)
NOTES
15
Mon 30 June
12:15 – 13:00
Tuesday 1 July Overview
TUESDAY 1 JULY 2014
TIME
SESSION DETAIL
ROOM
INFORMATION
09:00 – 12:10
Clinicopathological Cases
Lomond
Page 17
08:30 – 12:45
Bri sh Society of Cutaneous Allergy
Boisdale
Page 18
09:00 – 13:00
BADGEM
Dochart 2
Page 19
10:45 – 11:15
Hot Topics
Exhibi on
Page 52
11:15 – 17:30
Bri sh Society for Dermatological Surgery
Alsh
Page 20-22
12:30 – 14:00
Senior Skin Group
Dochart 1
Page 23
14:00 – 14:15
Opening Address
Lomond
Page 26
14:00 – 17:30
Bri sh Society for Dermatopathology
Boisdale
Page 24-25
14:15 – 14:45
Guest Lecturer: Professor Amrinder J Kanwar
Lomond
Page 26
Plenary Session – Submi ed Papers
Lomond
Page 26
15:45 – 16:15
Hot Topics
Exhibi on
Page 52
16:30 – 17:30
Dermatology Teachers
Dochart 1
Page 27
17:30 – 18:00
Guest Lecturer: Professor Robert Moots
Lomond
Page 26
18:00 – 20:00
Welcome Recep on
Glasgow Science Centre
Page 10
Tue 1 July
14:45 – 17:30
16
Clinicopathological Cases
Date:
Time:
Room:
Chair:
Tuesday 1st July
09:00-12:10
Lomond
Dr Thomas Brenn & Dr Manuraj Singh
Dr Eduardo Calonje & Dr Paul Craig
PROGRAMME
CPC03
Urticarial dermatitis: a presenting feature of lymphoma or just a variant of
Schnitzler’s syndrome?
F.R. Ali, L. Motta, A. Bloor and A.M. Marsland
09:07 – 09:14
CPC02
Lymphomatoid plaquosis- a novel cutaneous CD30+ T-cell lymphoma
spontaneously resolving and recurring on the same skin sites
C. Haddadeen, C. Lai, S-Y. Cho, A. Fityan, A. Bates, J. Theaker and E. Healy
09:14 – 09:21
CPC01
Erythema gyratum repens-like vasculitis
N. Spierings and J. Natkunarajah
09:21 – 09:28
CPC04
Mesenteric cysts in Gorlin syndrome: a mimic of metastatic disease
N. Rajan, S. Brown, S. Ward, P. Pieniazek, P. Hainsworth, F. Douglas, A. Husain and
R. Plummer
09:28 – 09:35
CPC05
Symmetrical Idiopathic MicroPapular FaciaL Eruption or SIMPLE – a case series
describing a new, distinct clinical entity characterised by lichen planopilaris
affecting vellus hairs in the absence of frontal fibrosing alopecia
J. Newsham, L. Motta, L.A. Jamieson and V. Madan
09:35 – 10:20
Joint BAD/BSD Neil Smith Lecture
Pitfalls and Controversies in Mesenchymal Tumours of the Skin
Professor Christopher Fletcher (Boston, USA)
The practice of pathology (including dermatopathology) is replete with surprisingly numerous
examples of unreliable dogma, outdated falsehoods, unsubstantiated claims and ‘lore’
handed down over decades. Many of these misconceptions are perpetuated informally and
are hard to dislodge. This talk will aim to address a selection of these issues.
10:20 – 11:00
Break
Exhibition Hall 5
11:00 – 11:07
CPC06
A rare case of cutaneous collagenous vasculopathy
N. Meah, J. Ellison and N. Khirwadkar
11:07 – 11:14
CPC07
Adult-onset pansclerotic morphoea
S. Aryiku and W. Perkins
11:14 – 11:21
CPC08
Beware of scrotal ulceration during induction chemotherapy with all-trans
retinoic acid
C. Foley and P. Marren
11:21 – 11:28
CPC09
Xanthoma disseminatum in a patient with B-cell acute lymphoblastic leukaemia
V.M. Smith, R. Rose and W. Merchant
11:28 – 11:35
CPC10
Fat necrosis secondary to a deficiency in protein C and antithrombin
C. Edwards, E. Agius, V. Akhras and J. Uprichard
11:35 – 11:42
CPC11
Periorbital and perioral oedema: an unreported presentation of reactive
haemophagocytic lymphocytosis
T.N. Shim, S.D. Orpin and T.M. Finch
11:42 – 11:49
CPC12
Subacute cutaneous lupus erythematosus occurring post-radiotherapy
D.Y.L. Tang, S. Whitaker and S. Wahie
11:49 – 11:56
CPC13
Suppurative variant of childhood periorificial granulomatous dermatitis
A. Kapadia and S. Attili
11:56 – 12:03
CPC14
A case of suspected human-to-human transmission of orf between mother and child
V. Rajkomar, M. Hannah, I. Coulson and C. Owen
12:03 – 12:10
CPC15
Trichodysplasia spinulosa-associated polyomavirus: a rare cutaneous complication
following renal transplantation
F.R. Ali, A. Aslam, L. Motta and J.T. Lear
17
Tue 1 July
09:00 – 09:07
Bri sh Society for Cutaneous Allergy
Date:
Time:
Room:
Chair:
Tuesday 1st July
08:30-12:45
Boisdale
Dr David Orton & Dr Donna Thompson
Dr Sarah Wakelin & Dr Mark Wilkinson
Tue 1 July
PROGRAMME
08:30 – 09:00
AGM
09:00 – 09:30
Prosser White Oration
Patch testing in the investigation of delayed drug eruptions
Dr Margarida Goncalo
09:30 – 09:40
CD01
Occupational exposure to propranolol: an unusual cause of allergic contact
dermatitis
F.R. Ali, D.B. Shackleton, T.P. Kingston and J.D.L. Williams
09:40 – 09:50
CD02
What is the relevance of contact allergy to sodium metabisulfite and which
concentration of the allergen should we use?
N. Ralph, S. Verma, S. Merry, A. Lally, B. Kirby and P. Collins
09:50 – 10:00
CD03
Is allergic contact dermatitis of the vulva as common as we think?
A tertiary centre experience
R. Seys Llewellyn, M. Shah and H. Bell
10:00 – 10:10
CD04
Occupational nitrile glove allergy to Pigment Blue 15
C. Reckling, A. Sheraz, M. Engfeldt and M. Bruze
10:10 – 10:20
CD05
Contact dermatitis to a footwear label with positive patch test to 2-monomethylol phenol
S. Ziaj, S. Zaheri and S. Wakelin
10:20 – 10:30
CD06
Paraphenylenediamine testing in strongly sensitized patients: an effective screen
R. Nalluri and J. Williams
10:30 – 11:15
Break
Exhibition Hall 5
11:15 – 11:35
Guest lecture
Methyl isothiazolinone: an update
Dr David Orton
11:35 – 11:45
CD07
Methylisothiazolinone and methylchloroisothiazolinone contact allergy: an
occupational perspective
R. Urwin, K. Warburton, M. Carder, R. Agius and M. Wilkinson
11:45 – 11:55
CD08
Methylisothiazolinone causing glue allergy in a furniture factory
C. Wlodek, C.R. Lovell and D.A. Buckley
11:55 – 12:05
CD09
Presumed airborne contact allergy to methylisothiazolinone in paint causing acute
severe facial dermatitis and respiratory difficulty
W. Alwan, I. White and P. Banerjee
12:05 – 12:15
CD10
Allergic contact dermatitis to Dermabond surgical glue mimicking orthopaedic
surgical implant allergy
C.P. Harkins, R.M.R. Hearn and S. Abdul Ghaffar
12:15 – 12:25
CD11
What happens to patients after they have been diagnosed with allergic contact dermatitis?
J. Simpson, C. Green and S. Abdul Ghaffar
12:25 – 12:35
CD12
A regional audit of cutaneous allergy services
V.M. Smith and M. Wilkinson
12:35 – 12:45
CD13
A survey of cosmetic product use and contact skin reactions in children
C. Cameron and S. Abdul Ghaffar
CD14
The use of alitretinoin for chronic hand eczema: results of a regional audit
N. Meah, V. Peers and M. Walsh
CD15
Simultaneous testing of oxidized and nonoxidized limonene and linalool in 80
consecutive patients referred for patch testing
S. Simpkin, K. Scharrer and J. Schofield
CD16
Characterization of T-lymphocyte responses to paraphenylenediamine
A. Popple, R. Dearman, I. Kimber, J. Williams, N. Gellatly and G. Maxwell
POSTERS
The poster viewing session will take place between 13:30 and 14:00 on Tuesday 1st July
18
BADGEM Clinical Mee ng
Date:
Time:
Room:
Chair:
Tuesday 1st July
09:00-13:00
Dochart 2
Prof Irene Leigh
Prof John McGrath
PROGRAMME
09:00 – 09:05
Welcome BADGEM Clinical Meeting – Professor Irene Leigh
BG01
Invited Talk 1
What’s new in Epidermolysis bullosa?
Professor John McGrath (London)
09:30 – 09:40
BG02
Case report 1
Ear complications in inversa type recessive dystrophic epidermolysis bullosa
(RDEB-I); a case series of 6 patients
Dr Susan Robertson (London)
09:40 – 09:50
BG03
Case report 2
Epidermolysis Bullosa Pruriginosa: Two novel COL7A1 mutations
Dr Arpita Debroy Kidambi (Sheffield)
09:50 – 10:15
BG04
Invited Talk 2
Ichthyoses: what’s new?
Dr Vinzenz Oji (Münster, Germany)
10:15 – 10:25
BG05
Case report 3
Progressive Osseous Heteroplasia
Dr Prativa Jayasekera (Liverpool)
10:25 – 10:35
BG06
Case report 4
Acral Peeling Syndrome secondary to CSTA gene mutation
Dr Kayria Muttardi (Watford)
10:35 – 10:55
Break
Exhibition Hall 5
10:55 – 11:20
BG07
Invited Talk 3
What’s new in keratodermas?
Professor Edel O’Toole (London)
11:20 – 11:30
BG08
Case report 5
Vohwinkel syndrome with a novel Loricrin microdeletion
Amjad Khan (London)
11:30 – 11:40
BG09
Case report 6
Bullous Icthyosis of Siemens
Dr Anna Dubois (Newcastle)
11:40 – 11:50
BG10
Case report 7
A novel RASA1 mutation presenting with multiple cutaneous capillary malformations
Dr Sairan Whitaker (Newcastle)
11:50 – 12:15
BG11
Invited Talk 4
New ways of diagnosing genetic skin disease
Professor David Kelsell (London)
12:15 – 12:25
BG12
Case report 8
Focal dermal hypoplasia (Goltz syndrome)
Dr Roland Chu (Edinburgh)
12:25 – 12:35
BG13
Case report 9
Annular erythema of infancy? A common disease pathway with atypical HUS
Dr Ting Seng Tang (Nottingham)
12:35 – 13:00
BG14
Invited Talk 5
XP and DNA repair. What can a national service offer?
Prof Robert Sarkany (London)
19
Tue 1 July
09:05 – 09:30
Bri sh Society for Dermatological Surgery
Date:
Time:
Room:
Chair:
Tuesday 1st July
11:15-17:30
Alsh
Dr Raj Mallipeddi & Dr Vindy Ghura
Dr Colin Fleming
Dr Graeme Stables & Dr Colin Fleming
Tue 1 July
PROGRAMME
11:15 – 11:23
DS01
Fluorescence confocal microscopy during Mohs micrographic surgery: will this
change everything?
E. Craythorne, M. Pavel, R. Mallipeddi, N. Sheth, R. Barlow and A. Bennassar
11:23 – 11:31
DS02
In vivo reflectance confocal microscopy prior to paraffin-fixed ‘slow’ Mohs
micrographic surgery can reduce the number of stages required to clear lentigo
maligna
M.-L. Daly, N. Anjum, M. Patel, R. Barlow, N. Sheth, R. Mallepedi and E. Craythorne
11:31 – 11:39
DS03
A competency-based assessment tool for Mohs micrographic surgery
W. Bakkour and V. Ghura
11:39 – 11:47
DS04
Wrong-site skin surgery in the U.K.: results of a web-based survey
S. Rajpara, A. Affleck and C. Fleming
11:47 – 11:55
DS05
Surgical margins identified as a major area of uncertainty in the management of
high-risk cutaneous squamous cell carcinoma
C. Proby, A. Affleck, L. Thompson, R. Currie, A. Evans, K. Farquhar, G. Gupta, K.
Hassan, L. Mackintosh, M. Mathers, C. McLean, C, Moyes, L. Naysmith, J. Norris, T.
Shoaib, M. Crumley, W. Ford, F. Oakey, A. Stein and J. Brown
BCDG Talk ‘Management of Surgical Scars’
Dr Nick Lowe (London)
12:00 – 12:30
12:30 – 12:38
DS06
A case series on the use of topical imiquimod 5% for severe and recurrent
keloid scarring
Z. Laftah, A. Ujam, N. Baksh, C. Huppa, K. Fan and S. Bashir
12:38 – 12:46
DS07
Clinical and treatment characteristics determining therapeutic outcome in patients
undergoing autologous noncultured outer root sheath hair follicle cell suspension
for treatment of stable vitiligo
K. Vinay, S. Dogra, D. Parsad, A. Kanwar, R. Minz and U. Saikia
12:46 – 12:54
DS08
Combined cell suspension transplantation in stable vitiligo
A.P. Holla
12:54 – 13:02
DS09
Modifications of cellular grafting in vitiligo: a new era of surgical management of vitiligo
D. Parsad
13:02 – 14:00
Lunch
Exhibition Hall 5
14:00 – 15:00
Focus Session - How to Get out of a Hole
Dr Vindy Ghura and Dr Tom Oliphant
The session will include: wounds that don’t want to close, vessels that won’t stop
bleeding, invaluable suture tricks and tips, simple flaps and much more
15:00 – 15:40
Guest Lecture
Dutch Masters: Lessons in Mohs Surgery from the Netherlands
Dr Nicole Kelleners-Smeets (Maastricht, The Netherlands)
15:40 – 16:00
Break
Exhibition Hall 5
16:00 – 16:08
DS10
Lagophthalmos secondary to facial nerve injury in bilobed transposition flap
reconstruction of the nasal side wall: a previously unreported complication in
dermatological surgery
C.B. Hackett, E. Barnes and J.A.A. Langtry
16:08 – 16:16
DS11
A 6-month prospective review of all nail presentations to a melanoma screening clinic
C.B. Hackett, H. Benbow, T.J. Oliphant and J.A.A. Langtry
16:16 – 16:24
DS12
Paradoxical hair stimulation following laser hair removal: a retrospective study
W. Szczecinska, Y. Mansouri, H. McMullin, K. Kitching, S. Lanigan and A. Abdullah
16:24 – 16:32
DS13
Mohs micrographic surgery in the U.K.: are we discriminating against people with
blood-borne infections?
B.S. McDonald and E.D. Seaton
20
16:32 – 16:40
DS14
Follicular proliferation or basal cell carcinoma? The first prospective U.K. study of
this histological challenge during Mohs surgery
N. Anjum, A. Robson, E. Craythorne and R. Mallipeddi
16:40 – 16:48
DS15
What is the best imaging modality for basal cell carcinomas of the external auditory
canal and pinna? Aiding Mohs micrographic surgery
S. Lokman, C. Perrett and S. Morley
16:48 – 16:56
DS16
Does compression improve wound healing when applied to lower-leg excisions left
to heal by secondary intention? The COMPRESS Survey
P. Jayasekera, P. Trehan, J. Collins, K.S. Chen, W. Hussain, C. Flohr and E.V. Pynn
16:56 – 17:04
DS17
Mohs micrographic surgery for the treatment of atypical fibroxanthoma: a case
series of 16 patients
U. Eke, C. Roberts, R. Hejmadi and J. Marsden
AGM
DS18
Castroviejo needle holder: a surgical tip for suturing at difficult anatomical sites
A. Patel and S. Varma
DS19
Merkel cell carcinoma: a U.K. tertiary referral centre 10-year surgical experience
I. Logan, M. Petkar, P. Dziewulski and A. Harrison
DS20
Laser treatment for female facial hirsutism: are quality-of-life benefits sustainable?
A. Roche, P. Sedgwick and C. Harland
DS21
Ingenol mebutate to treat Bowen disease: a case series
C. Kiely and C. Buckley
DS22
The use of an adipomuscular hinge flap for the reconstruction of deep lateral
alar defects
E. Higgins and R.B.M. Barry
DS23
Dermal piercings: unregulated high street surgery?
G. Parkins and M. Porter
DS24
Carbon dioxide laser treatments under general anaesthetic: analysis of 124
treatments over 4 years
W. Bakkour, V. Madan, S. Dolan and J. Ferguson
DS25
What is the role of ultrasound evaluation of lymph nodes in patients with high-grade
squamous cell carcinoma of the head and neck?
S. Mellor, K. Chow and G.B. Colver
DS26
Histological characteristics of primary cutaneous malignant melanoma excised
outside an established pigmented lesion screening clinic
S. Verykiou, J.A.A. Langtry and T.J. Oliphant
DS27
Full-thickness skin grafting is an effective option for the closure of lower limb
defects following removal of cutaneous lesions
H. Audrain, A. Bray and D. de Berker
DS28
An audit of Mohs micrographic surgery cases requiring two or more layers that
were retrospectively noted to have negative debulk specimens at an Irish tertiary
referral centre
C.A. Maguire, R.B.M. Barry and P. Ormond
DS29
The proximal Peng flap: novel use of the Peng flap (pinch modification of
advancement and rotation flaps) for proximal nasal dorsum defects in 14 patients
C.B. Hackett, T.J. Oliphant, C.M. Lawrence and J.A.A. Langtry
DS30
Experience in diagnosing melanoma among U.K. dermatology trainees:
a nationwide survey
C. Champagne, H. Audrain, J. Collins, M. Sommerlad, K. Warburton and B. Esdaile
DS31
Double-pass pulsed-dye laser therapy at 20-min interval for resistant
port-wine stain
M.R. Panchal and A. Abdullah
DS32
Enucleation of cylindromas in Brooke–Spiegler syndrome: a novel
surgical technique
D. Brass, N. Rajan, T.J. Oliphant and J.A.A. Langtry
DS33
Patient-reported outcome measure of pain experienced during administration of
local anaesthesia in cutaneous surgery: a tool for appraisal
M.F. Chin, R. Abbott, J.R. Ingram and R.J. Motley
DS34
High-energy laser therapy for the treatment of paradoxical hypertrichosis
E. Carras, L. Harris, C. Lavender and C. Harland
DS35
The use of nasalis hinge flap and full-thickness skin graft to recreate contour defect
in partial-thickness nasal supratip and tip wounds
E. Higgins and R.B.M. Barry
17:04 – 17:30
POSTERS
Tue 1 July
21
Tue 1 July
DS36
How should we close scalp wounds? A comparative evaluation of scalp excisions
from dermatology and plastic surgery departments at a teaching hospital
W. Hunt and E. McGrath
DS37
Overwhelming infection following routine skin surgery: a suggested guideline to
prevent surgical-site infection in high-risk cases
S. Anthony, K. Batta, F. Tatnall, M. Murdoch, S. Parida and K. Hawks
DS38
Clinical triage tool effective for giving squamoid basal cell carcinoma appropriate
treatment priority
G. Fremlin, A. Bray and D. de Berker
DS39
An audit on the surgical management of lentigo maligna and melanoma in situ
using the 5-mm surgical margin
W.Y. Haw, C. Henderson and M. Oakford
DS40
Carbon dioxide laser perforation and extirpation of steatocystoma multiplex
W. Bakkour and V. Madan
DS41
Safe surgical management of patients with implantable cardiac devices
N. Anjum, N. Child and H. Cooper
DS42
A retrospective study of the quality of histology sections for Mohs
micrographic surgery
M. Sivaramakrishnan, S. McPherson, A. Evans, S. Rajpara, C. Fleming and A. Affleck
DS43
The effect of blood pressure on bleeding in Mohs surgery
A. Kai, C.B. Hackett, T.J. Oliphant, J.A.A. Langtry and C.M. Lawrence
DS44
Treatment of red tattoo ink reaction with carbon dioxide laser and curettage
B. Kaur and V. Madan
DS45
Pinch grafting in chronic leg ulceration
P. Gazzani, J. Brockley and A. Ilchyshyn
DS46
The usefulness of performing regional scouting biopsies when assessing the
clinical significance of a diffuse population of dermal spindle cells when treating
lentigo maligna
C.A. Maguire, N. Leonard and R.B.M. Barry
DS47
Mohs micrographic surgery referrals in the U.K.: knowledge and perception of
Mohs surgeons among general practitioners and physicians in a region in London
S. Ziaj and D. Shah
DS48
Median lip fissure of the upper lip: first report of surgical treatment by excision and
Z-plasty repair
A. Kai, E.L. Speight and J.A.A. Langtry
DS49
Upper lip island pedicle flap repair following Mohs surgery: a case series of
41 patients
A. Kai, T.J. Oliphant, C.M. Lawrence and J.A.A. Langtry
The poster viewing session will take place between 13:30 and 14:00 on Tuesday 1st July
NOTES
22
Senior Skin Group
Date:
Time:
Room:
Chair:
Tuesday 1st July
12:30-14:00
Dochart 1
Dr Maggie Kirkup
PROGRAMME
12:30 – 13:00
13:00 – 14:00
SG1
Itchy skin conditions in the elderly
Dr Colin Long
AGM and Lunch
NOTES
Tue 1 July
23
Bri sh Society for Dermatopathology
Date:
Time:
Room:
Chair:
Tuesday 1st July
14:00-17:30
Boisdale
Dr Paul Craig & Dr Thomas Brenn
Dr Eduardo Calonje & Dr Manuraj Singh
PROGRAMME
14:00 – 14:30
AGM
Tue 1 July
14:30 – 14:35
Introduction and comments on posters
14:35 – 14:44
DP01
Using MITF immunostaining to estimate melanocyte density in lentigo maligna:
melanocyte density is greater in recurrent lentigo maligna
K. Farquhar and C. Moyes
14:44 – 14:53
DP02
Intravascular epithelioid haemangioma. Review of fifteen cases of a rare
malignant mimicker
E. Ieremia and E. Calonje
14:53 – 15:02
DP03
Eccrine syringosquamous metaplasia: a mimic of squamous cell carcinoma.
Clinicopathological analysis of six cases
W. Rickaby, T. Bracey, D. Harmse, U. Brudnick, B. Martin, E. Ieremia and E. Calonje
15:02 – 15:11
DP04
A ten-year retrospective audit of outcomes in patients undergoing sentinel lymph node
biopsy for melanoma
A. Khan, S.L.P. Chong, J. McGregor, N. Wijesuriya, R. Cerio, C.Harwood and G. Moir
15:11 – 15:20
DP05
The spectrum of dermal hyperneury. Report of six cases
E. Ieremia, V. Mudaliar, S. Kelly, B. Grech, P. Rodriguez, B. Martin and E. Calonje
15:20 – 15:29
DP06
Evaluation of follicular T-helper cells in primary cutaneous marginal zone B-cell
lymphoma
Z. Shukur, D. Greenblatt, M. Ally, F. Child and A. Robson
15:29 – 15:38
DP07
Marginal zone lymphoma, cutaneous lymphoid hyperplasia and atypical marginal
zone hyperplasia, unnecessary distinctions and confusion: a proposed solution
D. Greenblatt, S. Ziaj, M. Wain, T. Mitchell, S.J. Whittaker, S.L. Morris, F. Child and
A. Robson
15:38 – 15:47
DP08
BRAF inhibitor-associated squamoproliferative lesions: evidence of HPV infection
histologically but not virologically
M. Sommerlad, K. Purdie, H. Rizvi, C. Proby and C.A. Harwood
15:47 – 16:15
Break
16:15 – 17:00
Exhibition Hall 5
Guest lecture
What’s New in Cutaneous Soft Tissue Tumours?
Professor Christopher Fletcher
This talk will provide a brief overview of selected new topics regarding soft tissue lesions
of the skin, including newly recognised ‘entities’, molecular genetic insights and elements
of clinically important differential diagnosis.
17:00 – 17:06
DP09
Epstein–Barr virus associated mucocutaneous ulceration
S. Brown, N. Gopee, D. Televantou and C. Lawrence
17:06 – 17:12
DP10
Extensive cutaneous telangiectasia of the torso and limbs: diffuse large B-cell
lymphoma with intravascular invasion
E. Burden-Teh, D.M. Green, C.G. Millar and K.W. Shum
17:12 – 17:18
DP11
Pigmented follicular squamous cell carcinoma (a subgroup of basosquamous
melanocytic tumours)
R. Griffiths, N. Turnbull, J.J. Carter, D. Scott, A. Sanders and R.A. Carr
17:18 – 17:24
DP12
An unusual granulomatous variant of scleromyxoedema mimicking diffuse
granuloma annulare
S. Verykiou, A. Husain and S. Meggitt
DP13
Utility of step sections in skin punch biopsies
A. Rupani, A. Sa’d and M. Petkar
DP14
Audit of squamous cell carcinoma reporting reveals a high proportion of
follicular cases
J. Stephenson, R. Griffiths, N. Turnbull, D. Scott, A. Sanders and R.A. Carr
POSTERS
24
Clinicopathological features of Merkel cell carcinoma: a 10 year tertiary referral
centre experience
I. Logan, M. Petkar and D. Kamel
DP16
An immunohistochemical study of myoepithelial cells in cutaneous cystic
apocrine neoplasms
A. Wood, S.-L. Houghton and A. Biswas
DP17
Clustered scalp cysts: the uncommon naevus trichilemmocysticus
J. Collins and P. Hunasehally
DP18
Self healing juvenile cutaneous mucinosis
J. M. Gao, J. Mann, K. Abou-Alfa, E. Duarte-Williamson and Eduardo Calonje
DP19
Use of a proforma dramatically improves compliance with RCPath
recommendations for the histopathological reporting of squamous cell carcinoma
R. Griffiths, J. Stephenson, N. Turnbull, D. Scott, A. Sanders and R. Carr
DP20
Factor XIIIa identifies macrophages and cells of mesenchymal origin in human skin
K. Aljefri, C. Bacon, A. Husain and M. Haniffa
DP21
Twentyfour year retrospective review of the diagnosis and management of lentigo
maligna
S.H. Hussain, E. Rytina and P. Todd
DP22
Giant condylomata acuminata of Buschke and Lowenstein: a peristomal variant
Z.Z.N. Yiu, F.R. Ali and C.C. Lyon
DP23
Septal eosinophilic panniculitis associated with adalimumab therapy for dissecting
cellulitis of the scalp
P. Pratsou, R. Muc and M.R. Kaur
DP24
Post-irradiation morphoea: A report of two cases of an under recognized
complication of breast cancer treatment
C. Sinclair and A. Biswas
DP25
An unusual rash in the gluteal cleft
S. Casey, A. Bakshi, E. Calonje and M. Shah
The poster viewing session will take place between 15:50 and 16:15 on Tuesday 1st July
NOTES
25
Tue 1 July
DP15
Scien fic Session – submi ed papers
Date:
Time:
Room:
Chair:
Tuesday 1st July
14:00-18:00
Lomond
Prof Christopher Bunker & Dr Graham Sharpe
Tue 1 July
PROGRAMME
14:00 – 14:15
Official Opening and Welcome – Professor Christopher Bunker
14:15 – 14:45
Guest Lecture - Introduced by Professor Christopher Bunker
Vitiligo-an Indian perspective
Professor Amrinder J Kanwar (Greater Noida, India)
Vitiligo, commonly known as ‘phulwari’ in India is an acquired disorder of pigmentation
with a worldwide prevalence of around 0.5-1%. India is amongst the countries with
highest prevalence rates ranging from 0.25% to 8.8 %. Loss of cutaneous pigmentation
is the result of loss of melanocytes from basal layer of epidermis. Etiopathogenesis of
vitiligo is multifactorial and polygenic consisting of genetic, immunological, autoimmune,
neurogenic, growth factor defect and environmental factors. The key clinical finding
in vitiligo is the acquired onset of an in increasing number of depigmented macules,
patches and later even wide spread involvement of skin. Patients with vitiligo experience
psychosocial distress and social stigmatization due to widespread prejudices, taboos
and ignorance among general population. Various treatment options available include
medical therapy as well as surgical intervention. I will be covering most of these aspects
of vitiligo as seen in Indians.
14:45 – 15:00
O01
Population-based mathematical modelling by location analysis and optimisation
predicts that investment in phototherapy will widen access and yield financial savings
H. Jones, D. Shipley, L. Smith, V. Knight, P. Harper and A. Anstey
15:00 – 15:15
O02
Clinically-led referral management: meeting the challenge of increasing
dermatology referrals
J. Schofield, C. Armstrong, D. Jackson, K. Scharrer and V. Blankley
15:15 – 15:30
O03
The psychological burden of common skin diseases in 13 European countries
F. Dalgard, J. Kupfer and U. Gieler
15:30 – 16:15
Break
Exhibition Hall 5
16:15 – 16:30
O04
Interim analysis of STEVIE, a single-arm, open-label, multicentre study to evaluate
the safety of the Hedgehog pathway inhibitor vismodegib in patients with advanced
basal cell carcinoma
J. Lear, K. Fife, M. Gore, T.Guerrero-Urbano, R. Herd, R. Plummer, N. Basset Seguin, J.
Hansson, L. Mitchell, M. Starnawski and A. Hauschild
16:30 – 16:45
O05
Reflectance confocal microscopy in the management of patients treated with
topical 5% imiquimod for facial lentigo maligna
N. Anjum, M. Pavel, A. Coleman, A. Robson, C. Stefanato, R. Mallipeddi, R. Barlow and
E.Craythorne
16:45 – 17:00
O06
Topical diphencyprone immunotherapy as a treatment for cutaneous metastatic
malignant melanoma, squamous cell carcinoma and eccrine porocarcinoma: a
report of 15 cases
F. Worsnop, A. Kutty, F. Harper, B. Powell and V. Akhras
17:00 – 17:15
O07
Long-term efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody,
in patients with moderate-to-severe chronic plaque psoriasis: results from a
52-week randomized, double-blind, placebo-controlled multi-centre trial
S. Dogra, D.S. Krupashankar, P. Naidu and C.G. Prasanna
17:15 – 17:30
O08
Childhood mycosis fungoides: experience of 28 patients treated in a
phototherapy service
P. Laws, E. Pope and N. Shear
17:30 – 18:00
Guest Lecture – Introduced by Dr Graham Sharpe
Behçet’s Syndrome: a new approach
Professor Robert Moots (Liverpool)
26
Dermatology Teachers
Date:
Time:
Room:
Chair:
Tuesday 1st July
16:30-17:30
Dochart 1
Dr Minal Singh
PROGRAMME
16:30 – 16:45
DT01
Which learning resources do medical students prefer during their
dermatology placement?
R. Atkar and E. Topham
16:45 – 17:00
DT02
Dermatology teaching for medical students: are we inspiring the next generation?
A. Yaakub, C. Wootton and S. Cohen
17:00 – 17:15
DT03
17:15 – 17:30
DT04
Online dermoscopy: an innovative method for teaching a transferable skill
A.A. Atwan, J. Vyas, M. Gonzalez, V. Piguet and R. Gamanya
Evaluation of the educational climate for specialty trainees in dermatology
J.M.R. Goulding and V. Passi
POSTERS
OpenMed dermatology: selected and rated online resources to support
dermatology training and education
C. Sinclair, V. Scott-Lang, P. Gordon, N. Turner and A. Sergeant
DT06
A survey of oral dermatology education and training, knowledge and clinical
practice among dermatologists in the U.K. and Ireland
K. Heelan, M. Fitzgerald and D. McKenna
DT07
The case mix and referral patterns of general practitioner graduates of the
University College Dublin Diploma in Dermatology
I. McDonald, C. Fahy, F. Powell and F. Moloney
The poster viewing session will take place between 13:30 and 14:00 on Tuesday 1st July
NOTES
27
Tue 1 July
DT05
Wednesday 2 July Overview
WEDNESDAY 2 JULY 2014
TIME
SESSION DETAIL
ROOM
INFORMATION
08:00 – 08:45
Novar s Sponsored Symposium
Alsh
Page 29
08:00 – 08:45
Celgene Sponsored Symposium
Boisdale
Page 30
08:45 – 10:15
Plenary session – Understanding Pharma
Lomond
Page 31
08:45 – 10:45
Historical
Carron
Page 32
08:45 – 10:15
Commonwealth Session
Dochart
Page 33
08:45 – 10:15
Bri sh Teledermatology Society
Leven
Page 34
10:15 – 10:45
Guest Lecturer: Professor Sir Ian Kennedy
Lomond
Page 31
11:15 – 13:00
AGM – BAD members only
Lomond
11:30 – 12:30
Public Lecture
Alsh
Page 35
13:15 – 14:15
Novar s Sponsored Symposium
Boisdale
Page 36
13:15 – 14:15
Roche Sponsored Symposium
Carron
Page 37
13:15 – 14:15
Leo Pharma Sponsored Symposium
Dochart
Page 38
14:30 – 17:50
Plenary session - Medical Dermatology
Lomond
Page 39
14:30 – 18:00
Bri sh Society for Paediatric Dermatology
Alsh
Page 40-41
15:30 – 18:00
BAD and BDNG Joint Mee ng
Boisdale
Page 42
Hot Topics
Exhibi on
Page 52
19:30 – 00:00
Annual Dinner
Kelvingrove Museum
Page 10
Wed 2 July
16:15 – 16:45
28
Sponsored Symposium 1: Novar s Pharmaceu cals UK Ltd
Date:
Wednesday 2nd July
Time:
08:00-08:45
Room:
Alsh
Chair:
Prof Chris Griffiths
IL-17A: A New Era for Psoriasis
PROGRAMME
08:00 – 08:05
Chairman’s Introduction
Prof Chris Griffiths (Manchester)
08:05 – 08:15
Physiology and Importance of IL-17 in the Pathogenesis of Psoriasis
Prof Nick Reynolds (Newcastle)
08:15 – 08:25
Treatment Effectiveness – Should we be aiming higher?
Prof Brian Kirby (Dublin)
08:25 – 08:35
Anti-IL-17A Efficacy in The Treatment of Psoriasis
Prof Chris Griffiths (Manchester)
08:35 – 08:40
Panel Discussion & Questions from the Floor
All
08:40
Chairman’s Summary & Close
Prof Chris Griffiths (Manchester)
NOTES
Wed 2 July
29
Sponsored Symposium 2: Celgene
Date:
Wednesday 2nd July
Time:
08:00-08:45
Room:
Boisdale
Chair:
Prof Jonathan Barker
Pa ent Perspec ves on Psoriasis: Can we Deliver on Their Expecta ons?
PROGRAMME
08:00 – 08:01
Welcome & Introduction
Prof Jonathan Barker (London)
08:01 – 08:14
Patient Perspectives in the Management of Psoriasis: The Population-Based
Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey
Prof Lluis Puig (Barcelona)
08:14 – 08:27
Meeting Patient Expectations: Quality Standards in Psoriasis to Enhance Patient
Care
Dr Ruth Murphy (Nottingham)
08:27 – 08:40
Meeting Patient Expectations: Improving Treatment Options
Prof Jonathan Barker (London)
08:40 – 08:45
Questions & Discussion
All
Wed 2 July
NOTES
30
Understanding Pharma
Date:
Wednesday 2nd July
Time:
08:45-10:45
Room:
Lomond
Chair:
Dr Victoria Elegant & Mr Geoff Holmes
Working with Pharma: Regulatory Focus
PROGRAMME
08:45 – 09:15
UP01
Bringing the Patient in the centre of our Development
Dr Kim Kjoeller (Senior Vice President Global Development- Leo Pharma)
09:15 – 09:45
UP02
The Development Challenges of Proving Benefit versus Response in Cutaneous
T-cell Lymphoma
Dr William McCulloch (President, Alba BioPharm Advisors, Inc.)
09:45 – 10:15
UP03
How regulators can support innovation
Dr Ian Hudson (Chief Executive - Medicines and Healthcare Products Regulatory Agency)
10:15– 10:45
GL03
Guest Lecture - Introduced by Professor Christopher Bunker
Professional Regulation
Professor Sir Ian Kennedy (London)
NOTES
Wed 2 July
31
Historical Symposium
Date:
Time:
Room:
Chair:
Wednesday 2nd July
08:45 – 10:45
Carron
Dr Nick Levell
PROGRAMME
08:45 – 09:00
H01
Helen Ollendorff-Curth: the first lady of dermatology
K.E. Davies and P.D. Yesudian
09:00 – 09:15
H02
Celebrating dendritic cells in the skin: the legacies of Paul Langerhans and
Ralph Steinman
K. Aljefri and M. Haniffa
09:15 – 09:30
H03
Britain: land of tattooed people
S. Unter and A. Shipman
09:30 – 09:45
H04
Parthenium dermatitis: the scourge of India
J. Jeyatheswaran and P. Yesudian
09:45 – 10:15
HGL
10:15 – 10:45
Break
Guest Lecture
‘Eminent Glaswegians’
Prof Colin Munro (Glasgow)
Historical Tea
Please join us for Madeira cake and wine in memory of Robert Willan
Wed 2 July
POSTERS
H05
Alan Lyell (1917–2007) and his eponymous disease
A. Hamilton
H06
From ancient Indian potters to WWII pilots: the elaborate history of skin grafting
R. Jerrom, D. Jackson, A. Patel and S. Varma
H07
Dr Albert Sézary (1880–1956) and his monster cells
D. Tabor and V. Smith
H08
The rise and fall of topical corticosteroids in dermatology
R. Coelho and N.J. Levell
H09
History of retinoids: from blindness to beauty
N. Spierings and J. Natkunarajah
H10
Man and melanoma: a long battle through time
P. Mahendran and J. Natkunarajah
H11
Campbell Grieg de Morgan (1811–76): not just a spot diagnosis
D. Tabor and V. Smith
H12
Is Shakespeare to blame for the negative connotations of skin disease?
C. Wootton, N. Boyle and T. Bleiker
H13
Ferdinand-Jean Darier: a vivacious man
J. Collins, N. Ponnambath and M. Kalavala
H14
The end of an era: Donald L. Morton (1934–2014) – the pioneer of sentinel lymph
node biopsy
A.R. Shipman and B.C. Gee
H15
The history of local anaesthetic
A. Patel and S. Varma
H16
History of the use of radiation in dermatology
V.C.Y. Li and R.K. Lister
H17
From ancient civilization to the 21st century: acne treatment through the ages
K. Bhate and R. Simpson
The poster viewing session will take place between 16:00 and 16:45 on Wednesday 2nd July
32
Commonwealth Session
Date:
Wednesday 2nd July
Time:
08:45 – 10:15
Room:
Dochart
Chair:
Prof Vinod Sharma & Prof Amrinder J Kanwar
PROGRAMME
CS01
Childhood leprosy through post- leprosy elimination era : a retrospective analysis
of epidemiological and clinical characteristics of disease over eleven years from a
tertiary care hospital at North India
S. Dogra, T. Narang, G. Khullar, R. Kumar and Uma Saikia
08:55 – 09:05
CS02
09:05 – 09:15
CS03
09:15 – 09:25
CS04
The active edge, centre or adjacent normal skin have the better histological yield in
the diagnosis of tuberculoid leprosy
F. Srisaravanapavananthan, K. Satgurunathan and J. Fernando
A prospective case series evaluating efficacy and safety of itraconazole and
potassium iodide in rhinofacial conidiobolomycosis
T. Narang, M. Gupta, R. Kaur and A. Manhas
Amyloidosis cutis dyschromica in two siblings and review of the epidemiology,
clinical features and management
C. Mahon, F. Oliver, D. Purvis and K. Agnew
09:25 – 09:35
CS05
Fibroscan Monitoring for Liver Complications of Methotrexate Use in Dermatology Patients
A. Chandran, M. Rademaker, R. Vyas, A. Yung, E. Johns, R. Jurawan, J. Irwin and F. Weilert
09:35 – 09:45
CS06
A prospective study of childhood leprosy from 2001 to 2014
J. Seneviratne, J. Akarawita, N. Madarasinghe and C. Siriwardana
09:45 – 09:55
CS07
Leprosy controversies: in therapy and its elimination
K. Bhushan
09:55 – 10:05
CS08
A randomized comparative study between autologous noncultured epidermal cell
suspension, suction blister epidermal grafting and split-thickness skin grafting: a
quest to find a first-line surgical modality for the treatment of stable vitiligo
A. Budania, D. Parsad, S. Dogra and N. Khunger
10:05 – 10:15
CS09
Herpes zoster in Sri Lanka
D. Bandara, M.T. Wickramasinghe, R. Weerasekara, D. Dissanayake and W. Ranaraja
CS10
The challenge of managing pityriasis rubra pilaris: success at last with ustekinumab?
S.H. Foo, A. Rowe, M.B. Maheshwari and A. Abdullah
CS11
Psoriasis audit: secondary care vs. intermediate care for the assessment and
management of psoriasis
R. Atkar and E. Derrick
CS12
Pemphigus and associated comorbidities: a Canadian population-based study
K. Heelan, A. Maher, S. Walsh and N.H. Shear
CS13
Invasive granulomatous aspergillosis mimicking cervicofacial actinomycosis in an
immunocompetent host
S. Kumaran and S. Dogra
CS14
Skin disease and infective endocarditis: a review of cases in New Zealand children, 994–03
C. Mahon, H. Cheng, R. Webb, D. Purvis and K. Agnew
CS15
An uncommon fungal infection of the skin associated with granulocytic sarcoma: a
diagnostic dilemma
K. Mallawaarachchi, S. Mendis, S. Ratnayake
CS16
Autologous serum skin test vs. autologous plasma skin test in patients with chronic
spontaneous urticaria: is there a response correlation?
S. Kumaran, S. Manal and D. Parsad
CS17
Deep vein thrombosis following thalidomide therapy in a patient with erythema
nodosum leprosum receiving multibacillary multidrug therapy and prednisolone
A. Budania and H.K. Kar
CS18
Clinical and investigational profile of herpes genitalis in a tertiary care centre
A. Itty, B. Joy and R. Sridharan
CS19
A survey of dermatological conditions in northern India: are we seeing changes
reflecting urbanization?
F. Latheef and Roland Strauss
POSTERS
Moxifloxacin-based regimens in leprosy: interim observations on occurrence of
reactions and bacterial decline
V.V. Pai
The poster viewing session will take place between 10:45 and 11:15 on Wednesday 2nd July
CS20
33
Wed 2 July
08:45 – 08:55
Bri sh Teledermatology Society
Date:
Time:
Room:
Chair:
Wednesday 2nd July
08:45 – 10:15
Leven
Dr Colin Morton & Dr Carolyn Charman
PROGRAMME
Welcome Introduction
Dr Colin Morton and Dr Carolyn Charman
Overview of UK Teledermatology including NHS and private services
08:45 – 09:00
09:00 – 09:15
BTS01
Rapid clinical review of patients assessed by a teledermatology service: analysis of
pathways and outcomes
Y. Liew, D. de Berker and J. Sansom
09:15 – 09:30
BT02
Teledermatology using ‘Choose and Book’: a review of 1000 patient referrals
C. Charman, H. Whitley and P. Bogucki
09:30 – 10:00
BTG
Guest Lecture
The NHS e-referral Service: A Programme Update optimising options for NHS teledermatology
Liz Barfield
Senior Implementation Manager
NHS e-Referral Service (Choose and Book) Programme
Health and Social Care Information Centre (HSCIC)
10:00 – 10:15
AGM
Wed 2 July
NOTES
34
The British Association of Dermatologists invite
the public to a Dermatology Question Time.
The session, hosted by Journalist, Broadcaster and former BBC &
ITN newscaster Martyn Lewis will be held on 2nd July
from 11.30 to 12.30 in the Alsh Room at the SECC, Glasgow
as part of the British Association of Dermatologists Annual Meeting.
Members of the public can ask questions of a distinguished panel of experts and join
in the debate on wide-range of skin-health related issues.
The event is free but attendees need to register in advance by emailing:
conference@bad.org.uk
•
•
•
Around 13 million people a year visit their GP in relation to a skin condition.
Skin cancer is the most numerous cancer in the UK and is increasing in
incidence.
Hand eczema is one of the most common reasons for disablement benefit in
the UK
The Panel – Chaired by Martyn Lewis
Dr David Orton
Consultant Dermatologist
Dr Tamara Griffiths
Consultant Dermatologist
Professor Lesley Rhodes
Professor of Experimental Dermatology, University of Manchester, and Hon
Consultant Dermatologist, Salford Royal Hospital
Dr Daniel Kemmett
Consultant Dermatologist
www.bad.org.uk l 020 7383 0266 l Charity reg no. 259474 l Willan House, 4 Fitzroy Square, London W1T 5HQ l @healthyskin4all
35
Wed 2 July
Who should attend?
Anyone interested in skin-health or skin-conditions
Representatives from local patient support groups
Students with an interest in health
Occupational health workers
Union representatives
Employers
Health workers
Sponsored Symposium 3: Novar s Pharmaceu cals UK Ltd
Date:
Time:
Room:
Chair:
Wednesday 2nd July
13:15-14:15
Boisdale
Dr Clive Gra an
Omalizumab: A new op on for addressing unmet clinical needs in Chronic Spontaneous
Ur caria (CSU)
PROGRAMME
13:15 – 13:18
Welcome & Introduction
Dr Phil Hammond (London)
Navigating the challenges in CSU
13:18 – 13:25
Confirming diagnosis and assessing impact on quality of life
Dr Clive Grattan (Norwich)
13:25 – 13:35
Limitations of current treatment options and guidelines
Dr Tabi Leslie (London)
Omalizumab in CSU: From trial to clinic
13:35 – 13:50
Phase III data: Efficacy and safety in CSU
Dr Clive Grattan (Norwich)
13:50 – 14:00
Real-world patient outcomes
Dr Alexander Marsland (Manchester)
Panel discussion and summary
14:00 – 14:12
Q & A with symposium faculty
Facilitated by Dr Phil Hammond (London)
14:12 – 14:15
Closing Remarks
Dr Clive Grattan (Norwich)
Wed 2 July
NOTES
36
Sponsored Symposium 5: Roche Products Ltd
Date:
Wednesday 2nd July
Time:
13:15-14:15
Room:
Carron
Chair:
Dr John Lear
Erivedge® ▼ (vismodegib) in advanced Basal Cell Carcinoma pa ents inappropriate for
surgery or radiotherapy – A UK case study based approach
PROGRAMME
13:15 – 13:20
Welcome & Introduction
Dr John Lear (Manchester)
13:20 – 13:35
Targeting the hedgehog pathway in advanced Basal Cell Carcinoma inappropriate
for surgery of radiotherapy
Dr John Lear (Manchester)
13:35 – 13:50
UK Patient case studies – an MDT based approach
Dr Kate Fife (Cambridge) and Mr Amer Durrani (Cambridge)
14:05 – 14:15
Closing Remarks
Dr John Lear (Manchester)
This promo onal symposium has been organised by Roche Products Limited
Prescribing Informa on
ERIVEDGE®▼ (vismodegib) 150 mg hard capsules Indica on: Erivedge is
indicated for the treatment of adult pa ents with:
• symptoma c metasta c basal cell carcinoma (mBCC)
• locally advanced basal cell carcinoma (laBCC) inappropriate for surgery or
radiotherapy.
Dosage and administra on: Recommended daily dose is 150 mg taken orally
with or without food. Swallow capsules whole with water. If a dose is missed
resume with the next scheduled dose.
Treatment interrup ons of up to 4 weeks were allowed based on individual
tolerability. In clinical trials, treatment with Erivedge was con nued un l disease
progression or un l unacceptable toxicity.
Contraindica ons: Women who are pregnant, breast feeding or women of
childbearing poten al (WCBP) who do not comply with the Erivedge Pregnancy
Preven on Programme. Hypersensi vity to the ac ve substance or excipients.
Coadministra on of St John’s wort (Hypericum perforatum)
Excipients: Erivedge contains lactose monohydrate, therefore pa ents with
galactose intolerance, primary hypolactasia or glucose-galactose malabsorp on
should not take this medicinal product. Interac ons: Concomitant treatment
with strong CYP inducers (e.g. rifampicin, carbamazepine or phenytoin) should
be avoided, as a risk for decreased plasma concentra ons and decreased
efficacy of vismodegib cannot be excluded.
Precau ons and Warnings: Embryo-foetal death or severe birth defects: Due
to the risk of embryo-foetal death or severe birth defects women taking
Erivedge must not be pregnant or become pregnant during treatment and for
24 months a er the final dose. If the pa ent does become pregnant, misses
a menstrual period, or suspects for any reason that she may be pregnant,
NOTES
37
Wed 2 July
she must no fy her trea ng physician immediately. Counselling: WCBP and
men who are prescribed Erivedge must comply with the Erivedge Pregnancy
Preven on Programme. WCBP must use two methods of recommended
contracep on, including one highly effec ve method and a barrier method
during Erivedge therapy and for 24 months a er the final dose. For men:
Erivedge is contained in semen. Male pa ents should not donate semen
while taking Erivedge and for 2 months a er the final dose. To avoid poten al
foetal exposure during pregnancy, male pa ents must always use a condom
(with spermicide, if available), even a er a vasectomy, when having sex with
a female partner while taking Erivedge and for 2 months a er the final dose.
Blood dona on: Pa ents should not donate blood while taking Erivedge
and for 24 months a er the final dose. Cutaneous squamous cell carcinoma
(cuSCC): Pa ents with advanced BCC have an increased risk of developing
cuSCC. All pa ents should be monitored rou nely while taking Erivedge, and
cuSCC should be treated according to the standard of care.
Sponsored Symposium 4: LEO Pharma
Date:
Wednesday 2nd July
Time:
13:15-14:15
Room:
Dochart
Chair:
Dr Colin Morton
Dermatology: Whose job is it anyway? A mul -disciplinary debate of the current and future
direc on of dermatology care
PROGRAMME
13:15 – 14:15
Faculty: Mr Taimur Shoaib (Glasgow)
Dr George Moncrieff (Bicester)
Dr Stephen Keohane (Portsmouth)
Discussion topics:
How can we achieve the optimal patient pathway between primary and secondary care?
How much dermatology can be effectively managed in the community?
What should the dermatology service look like in ten years’ time?
Summary and close
Wed 2 July
NOTES
38
Medical Dermatology & Submi ed Papers
Date:
Time:
Room:
Chair:
Wednesday 2nd July
14:30 – 17:50
Lomond
Dr Sarah Walsh & Dr Nick Levell
Dr Tabi Leslie & Dr Mike Ardern-Jones
PROGRAMME
Psychological aspects of psoriasis
Dr Sandy McBride (London)
Do the brains of psoriasis patients exhibit neuroinflammation?
H.J.A. Hunter, R. Hinz, X. Su, P.P.S. Talbot, A. Gerhard, C.E.M. Griffiths and C.E. Kleyn
14:30 – 14:55
MD01
14:55 – 15:10
O09
15:10 – 15:25
O10
Oral ciclosporin compared against prednisolone in pyoderma gangrenosum: a
randomized controlled trial
A. Ormerod, J. Norrie, E. Harrison, E. Mitchell, K. Thomas, H. Williams, Stop Gap Trial
Group Collaborators, N. Greenlaw, J. Mason, and F. Craig
15:25 – 15:50
MD02
Atopic eczema: new concepts in pathogenesis and treatment
Dr Mike Ardern-Jones (Southampton)
15:50 – 16:05
O11
Shared decision-making in plaque psoriasis: development of an Option Grid to
assist in decisions to commence oral therapy
E. Farrell, R. Whistance, A. Lloyd, M.-A. Durand, A. Jones, G. Elwyn and R. Motley
16:05 – 16:45
Break
Exhibition Hall 5
16:45 – 17:10
MD03
Ehlers Danlos and PXE
Dr Nigel Burrows (Cambridge)
17:10 – 17:25
O12
A 10-year review of patients with vulval vestibulitis syndrome referred into a
multidisciplinary clinic
E.E. Merika, C. Borysiewicz, S. Zaheri, J. Carton, A. Toczek, D. Lyons, M. Byrne and J. Setterfield
17:25 – 17:50
MD04
Skin problems of HIV post HAART
Dr David Paige (London)
Wed 2 July
NOTES
39
Bri sh Society for Paediatric Dermatology
Date:
Time:
Room:
Chair:
Wednesday 2nd July
14:30 – 18:00
Alsh
Dr Mary Glover & Dr Ruth Murphy
Wed 2 July
PROGRAMME
14:30 – 14:40
PA01
The genetic basis of phakomatosis pigmentovascularis type II
R. Waelchli, A. Thomas and V. Kinsler
14:40 – 14:50
PA02
Assessing the reliability of exome sequencing to detect the filaggrin null mutations
R501X and 2282del4
B. Thompson, D. Hawcutt, D. Carr, K. Bloch, A. Swale, R. Smyth and M. Pirmohamed
14:50 – 15:00
PA03
Propranolol In the Treatment of Complicated Haemangiomas (PITCH): the European
perspective
E. Wedgeworth, E. Baselga, J. Bjerre, M. Deleuran, V. Dorkova, R. Foelster-Holst, M.
Glover, L. Hedelund, A. Hernandez-Martin, P. Hoeger, A. Irvine, I. Neri, A. Oranje, A.
Patrizi, J. Ravenscroft, H. Shahidullah, L. Solman Koustic, A. Svensson, C.-F. Wahlgren
and C. Flohr
15:00 – 15:10
PA04
Facial port wine stain and glaucoma: an audit in two tertiary laser units
R. Raghavendran, A. Abdullah and M. Ogboli
15:10 – 15:20
PA05
Propranolol-related hypoglycaemic seizure in a 9-month-old infant: the importance
of regular feeding throughout the course of treatment
D. Owen and J. Hughes
15:20 – 15:30
PA06
Naevus spilus congenital melanocytic naevi: a distinct genotype for a distinct
phenotype
V. Kinsler, S. Krengel and R. Waelchli
15:30 – 16:15
PGL1
Guest Lecture
Elhers Danlos Syndrome in Childhood
Dr Glenda Sobey (Sheffield)
16:15 – 16:45
Break
Exhibition Hall 5
16:45 – 16:53
PA07
Peeling the surface of cystatin A defects
K. Muttardi, D. Nitoiu, D.P. Kelsell, E.A. O’Toole and K. Batta
16:53 – 17:01
PA08
Enterovirus infection mimicking eczema herpeticum: a new entity?
V. Scott-Lang, C. Sinclair, J. Yoo, N. Nwafor, H. Harvala, B. Dylan and S. Olivia
17:01 – 17:09
PA09
Ichthyosis with striate keratoderma caused by a compound heterozygous mutation
in ichthyin/NIPAL4
M. Sommerlad, C. Scott, C. Harwood, D. Kelsell and E. O’Toole
17:09 – 17:17
PA10
The effectiveness of a written treatment plan in the management of children with
atopic eczema
C. Duhovic, M. Mohsin, E. Duarte-Williamson and S. Baron
17:17 – 17:25
PA11
Disease severity measures and quality of life in atopic eczema in children
Z.K. Jabbar-Lopez, S. Darne, A.E.M. Taylor and N.J. Reynolds
17:25 – 18:00
PGL2
Guest Lecture
Paediatric Dermatology in Tanzania
Dr Susannah Baron (Canterbury)
PA12
An interesting case of keratin-1-mutation epidermolytic epidermal naevus and
unilateral distal limb aplasia
Y. Oon, C. Charman, E. Kivuva and D. Bartle
PA13
Multifocal lymphangioendotheliomatosis with thrombocytopenia
K. Aljefri, F. Charlton, S. Leech and A.E.M. Taylor
PA14
The perineal groove: an uncommon congenital anomaly of the perineum
E. Higgins, F. Quinn and R. Watson
PA15
Spontaneously regressing eruptive disseminated Spitz naevi
B. Bhoyrul, D. Tang, C. Harikumar and A. Carmichael
PA16
An interesting presentation of papular xanthomas in a 5-year-old girl
R. Seys Llewellyn, A. Alsharqi and R. Parslew
POSTERS
40
Coxsackievirus A6 preferentially affecting children with atopic dermatitis in the U.K.
M. Lynch, A. Sears, H. Cookson, T. Lew, Z. Laftah, E. Orrin, M. Zuckerman, D. Creamer
and E. Higgins
PA18
Lamellar ichthyosis with a novel mutation in the ABCA12 gene
F. Latheef, M. Shareef and B. Walker
PA19
Neonatal lupus erythematosus with life-threatening gastrointestinal bleeding
V. Dvorakova, B. Nolan, A. Broderick, E.J. MacDermott and R. Watson
PA20
Influenza vaccination as a novel trigger of Wells syndrome in a child
J. Simpson, R. Patalay, N. Roberts and Nick Francis
PA21
Successful treatment of chronic bullous disease of childhood with rituximab
N. Farquharson, R. Wynn and T. Clayton
PA22
Invasive fungal dermatitis of the very low birthweight infant
A. Fonia, C. Kennedy, P. Mannix and C. Platt
PA23
A case of blueberry muffin baby associated with a blastic plasmacytoid dendritic
cell neoplasm
A. Lloyd-Lavery, J. Aspel, S. Wilson, K. Lakhoo, E. Soilleux and T. McPherson
PA24
Bathing suit ichthyosis and 22q11.2 duplication
A. Khan and A. Harrison
PA25
Bullous erythrodermic rash in a neonate: diffuse cutaneous mastocytosis
R. Davies, R. El-Sharkawi and S. Blackford
PA26
Pachydermodactyly: an unusual case of swollen fingers managed successfully with
surgery
F. Latheef and D. Fairhurst
PA27
Familial myofibromatosis associated with germline CDKN2A mutations
K. Aljefri, A. Dubois, A. Husain, A. Henderson, N. Rajan and S. Leech
PA28
Imiquimod cream for treatment of a child with Gorlin syndrome
Y. Robson and R. Goodwin
PA29
Hypopigmented mycosis fungoides in a 4-year-old Zimbabwean boy
V.M. Smith and S. Clark
PA30
Hypothyroidism and hepatic haemangiomas: highlighting the link
C. Wootton and J. Ravenscroft
PA31
A boy and his guinea pig: the importance of taking a pet history
S. Ayob, N. Aldoori and M. Cork
PA32
X-linked ichthyosis: a rare mutation and dramatic improvement with topical therapy
B. McDonald and B. De Silva
PA33
Recurrent eczema herpeticum secondary to herpes simplex virus type 2: a case
study and review of the literature
F. Meredith and F. Muller
PA34
Microsporum audouinii infection complicating atopic dermatitis in a 5-year-old girl
P. Gazzani, W. Szczecinska and A. Ilchyshyn
The poster viewing session will take place between 16:15 and 16:45 on Wednesday 2nd July
NOTES
41
Wed 2 July
PA17
BAD & BDNG Joint Session
Date:
Wednesday 2nd July
Time:
15:30 – 18:00
Room:
Boisdale
Chair:
Dr Jane Se efield & Karen Stephen
Case Studies of Partnership or Mul Disciplinary Team working
PROGRAMME
15:30 – 15:50
JM01
Tackling complex mucocutaneous diseases: the benefits of an MDT approach
Dr Jane Setterfield
15:50 – 16:10
JM02
Psychology
Dr Andrew Thompson
16:10 – 16:30
JM03
Genetics with an emphasis on EB
TBC
16:30 – 17:00
Break
Exhibition Hall 5
17:00 – 17:20
JM04
Podiatry
Dr Ivan Bristow
17:20 – 17:40
JM04
Why multi disciplinary team working is important in vulval disease
Dr Jennifer Yell
17:40 – 18:00
JM05
Paediatric
Karen Pett
Wed 2 July
NOTES
42
Thursday 3 July Overview
THURSDAY 3 JULY 2014
TIME
SESSION DETAIL
ROOM
07:45 – 08:45
Chris an Medical Fellowship Breakfast
Ness
INFORMATION
08:45 – 12:40
Plenary Session Professors & Registrars forum
Lomond
Page 44
08:45 – 12:45
Bri sh Photodermatology Group
Alsh
Page 45
08:50 – 12:30
Bri sh Society for Skin Care in Immunocompromised Individuals
Carron
Page 46-47
13:30 – 14:15
Arthur Rook Ora on: Dr Rachael Clark
Lomond
Page 48
13:30 – 17:00
CPD update
Lomond
Page 48
14:15 – 17:00
Focus Session - Alopecia
Alsh
Page 49
15:00 – 15:30
Focus Session - Itch
Boisdale
Page 49
15:00 – 15:30
Focus Session - Hyperhidrosis
Carron
Page 49
Thur 3 July
43
Professors & Registrars Forum
Date:
Time:
Room:
Chair:
Thursday 3rd July
08:45 – 12:40
Lomond
Dr David Eedy & Prof Irene Leigh
Dr Richard Groves & Prof Eugene Healy
Thur 3 July
PROGRAMME
08:45 – 09:00
PRES
Presidents Address
Dr David Eedy
09:00 – 09:15
RF01
Severity of polymorphic light eruption in pre- and postmenopausal women: a
comparative study
H. Reddy, S. Wahie and A.J. Carmichael
09:15 – 09:30
RF02
Yellow nail syndrome: a primary lymphatic disorder?
Z. Jiyad, E. Cousins, A. Stanton and P. Mortimer
09:30 – 09:50
PR01
Title TBC
Prof Anthony Ormerod (Aberdeen)
09:50 – 10:05
RF03
Novel mutation in loricrin presenting with prominent ichthyosis
F. Cunningham, E. Pohler, A. Sandilands, C. Cole, F. Smith, I. McLean, C. Munro and M.
Zamiri
10:05 – 10:20
RF04
Meeting the NICE guideline: a simple, targeted ultrasound protocol for the detection
of early psoriatic arthritis in patients with severe psoriasis
L. Savage, A. Jackson, M. Goodfield and D. McGonagle
10:20 – 10:40
PR02
Psoriasis
Prof David Burden (Glasgow)
10:40 – 11:10
Break
Exhibition Hall 5
11:10 – 11:25
RF05
Self-generated lysophosphatidic acid gradients are a key driver of melanoma cell
dispersal & invasion
A. Muinonen-Martin, W. Faller, O. Susanto, O. Sansom, L. Machesky, R. Insall, M.
Wakelam, Q. Zhang, R. Herd, R. Jones, D. Bennet and D. Knecht
11:25 – 11:40
RF06
Skin-related mortality after kidney transplantation in England between 2001 and
2012: a population-based cohort analysis
H. Church, D. Farrugia, I. Begaj, D. Ray and A. Sharif
11:40 – 12:00
PR03
Personalising systemic therapy in Psoriasis
Prof Catherine Smith (London)
12:00 – 12:15
RF07
Determinants of Varicella Zoster Virus replication in skin
M. Singh
12:15 – 12:30
RF08
Induction of dermal papilla properties in highly potent CD271+CD90+ mesenchymal
stem cells generated from human-induced pluripotent stem cells
O. Veraitch, Y. Mabuchi, Y. Matsuzaki, M. Amagai, H. Okano and M. Ohyama
12:30 – 12:40
PR04
Update on BADBIR
Prof Chris Griffiths (Manchester)
NOTES
44
Bri sh Photodermatology Group
Date:
Time:
Room:
Chair:
Thursday 3rd July
08:45 – 12:45
Alsh
Prof James Ferguson & Dr Robert Sarkany
Dr Victoria Goulden & Dr Robert Dawe
PROGRAMME
PD01
British Association of Dermatologists and British Photodermatology Group guidelines
for the safe and effective use of psoralen combined with ultraviolet A therapy 2014
T.C. Ling, T.H. Clayton, J. Crawley, L.S. Exton, V. Goulden, S. Ibbotson, K. McKenna,
M.F.M. Mustapa, L.E. Rhodes, R. Sarkany and R.S. Dawe
09:00 – 09:35
PDGL1
Guest Lecture
Measuring photoprotection behaviour in normals and patients
Prof Hans Christian Wulf (Copenhagan)
09:35 – 10:10
PDGL2
Guest Lecture
FRS: The XP population in the UK: unexpected clinical features and relationship to
molecular defects
Prof Alan Lehmann (Brighton)
10:10 – 10:25
PD02
Clinical and molecular analysis of 13 XP-A patients from the U.K.: genotype–
phenotype correlation with prognostic importance
M. Sethi, S. Haque, A. Lehmann, S. Mohammed, N. Chandler, D. McGibbon, R. Sarkany
and H. Fassihi
10:25– 10:45
Break
Exhibition Hall 5
10:45 – 11:00
PD03
A novel automated method to assess photodamaged skin
O.S. Osman, K. Naidoo, V. Bataille, S. Jassim, K. Langlands and J. Selway
11:00– 11:15
PD04
Retrospective study of patients with idiopathic solar urticaria: cohort of 45 cases
M. Sivaramakrishnan and S. Ibbotson
11:15 – 11:30
PD05
Hydroa vacciniforme associated with persistent Epstein–Barr virus infection in four
patients: clinicopathological studies and response to antiviral therapy
A. Fityan, R. Sarkany, A. Robson, E. MacMahon, N. Martinez-Alier and H. Fassihi
11:30 – 11:45
PD06
Is there a role for filaggrin mutations in the pathogenesis of chronic actinic dermatitis?
C.P. Harkins, A. Waters, A. Kerr, L. Campbell, W.H.I. McLean, S.J. Brown and S.H. Ibbotson
11:45 – 12:00
PD07
Hendle syndrome: a new entity comprising polymorphic light eruption with suntriggered acute fatigue syndrome and solar catarrh, associated with recurrent
severe sore throats in childhood followed by polychondritis with sacroileitis
D. McGibbon, H. Fassihi, R. Sarkany, S. Sangle and D. D’Cruz
12:00 – 12:15
PD08
Indian experience of a 308-nm monochromatic excimer lamp in 400 cases of vitiligo
A. Shah and B. Shah
AGM
PD09
Safety of patients fitted with electronic artificial implanted devices in ultraviolet
treatment cubicles
D. Turner, J. Britton, N. Tassell, D. Bird and V. Goulden
PD10
Retrospective analysis of 12 patients with cutaneous graft-versus-host disease
treated with phototherapy and psoralen combined with ultraviolet A
S. Rajan, T. Clarke and M.G.S. Dunnill
PD11
An evaluation of psoriasis patient preferences between systemic psoralen
combined with ultraviolet A (PUVA) and bath PUVA
D. Alshiyab, M.F. Chin, C. Edwards and A.V. Anstey
PD12
A rare adverse event in TL-01 phototherapy: a case series of four patients
C.M.R. Fahy, I. McDonald, L. Gaynor, N. Mulligan, P. Lenane and F.J. Moloney
PD13
Recall of provision of sun protection advice to patients with cystic fibrosis taking
voriconazole
L. Cunningham, M. Moran, C. Keating, E. McKone, C. Gallagher and A. Lally
PD14
Porphyria cutanea tarda precipitated by ultraviolet nail lamp
O. Abdulla, R. Sarkany and Kap
12:15 – 12:45
POSTERS
The poster viewing session will take place between 13:00 and 13:30 on Thursday 3rd July
45
Thur 3 July
08:45 – 09:00
Bri sh Society for Skin Care in Immunocompromised Individuals
Date:
Time:
Room:
Chair:
Thursday 3rd July
08:50 – 12:30
Carron
TBC
PROGRAMME
08:50 – 08:55
Welcome & Introduction by Dr Charlotte Proby
INTERACTIVE CASE DISCUSSION with Expert panel
09:00 – 09:05
BI01
Cutaneous leishmaniasis while taking adalimumab for psoriasis
V.M. Smith and V. Goulden
09:05 – 09:10
BI02
Aspergillosis pneumonia as a fatal complication of recalcitrant severe bullous pemphigoid
M.F. Chin, K. May and M.M.U. Chowdhury
09:10 – 09:15
BI03
Too much hair, not enough hair and acne after a kidney transplant: it’s not always
the drugs
R. Atkar and C. Harwood
09:15 – 09:20
BI04
Noduloulcerative skin lesions in an HIV-positive man: an increasingly common
presentation of an ancient disease
M. Krupiczojc, P. Goldsmith, R. Cerio, C. Orkin, E. Williams and C. Harwood
09:20 – 09:25
BI05
A rare presentation of graft-versus-host disease 6 years post-liver transplant
A. Jamil, T. Desai and M. Muzaffar
09:25 – 09:35
Discussion time
09:35 – 09:40
BI06
Legionella feeleii: A novel organism associated with cutaneous infections in
immunocompromised patients
S. Verykiou, C. Goodhead and S. Meggitt
09:40 – 09:45
BI07
Granulomatous inflammation associated with common variable immunodeficiency:
case report and review of the literature
S. George, R. Chee and C. DeGiovanni
09:45 – 09:50
BI08
Rosacea: a rare presentation of immune reconstitution inflammatory syndrome
S. Karanovic, S. George, E. Topham and F. Cresswell
09:50 – 09:55
BI09
Papular pruritic eruption of HIV responsive to oral thalidomide
A. Wernham and S.-L. Chua
09:55 – 10:05
Discussion time
Thur 3 July
10:05 – 10:15
Poster round up
10:15 – 11:00
Break
Exhibition Hall 5
11:00 – 11:35
BIGL
Guest Lecture
Current surgical dilemmas in the management of high risk SCC
Roger Currie & Carrie Newlands (both BAOMS)
11:35 – 11:45
BI10
Skin cancer after haematopoietic stem cell transplant: is long-term skin cancer
surveillance required?
S. Chinthapalli, J. McGregor and C. Harwood
11:45 – 11:55
BI11
Adherence to vaccination guidelines in dermatology patients on
immunosuppressive therapy: an opportunity for improvement
M. Sadlier, C. Sadlier, A. Alani, K. Ahmad, C. Bergin and B. Ramsay
11:55 – 12:05
BI12
Risk of skin cancer in patients with inflammatory bowel disease
J. Clowry, J. Sheridan, D. Keegan, K. Byrne, H. Comber, S. Deady, G. Cullen, H.
Mulcahy, G. Doherty and A. Lally
12:05 – 12:30
AGM
POSTERS
BI13
Dermatophytic panniculitis in a postrenal transplant patient
M. Arunachalam, M. Galeone, A. Bassi and E. Difonzo
BI14
An eruption of plaques on the lower leg in an immunocompromised patient
P. Trehan, N. Khirwadkar, A. Al-Sharqi and Milli Shah
BI15
Rosacea-like dermatosis in a patient with X-linked chronic granulomatous disease
treated effectively with hydroxychloroquine
K.S. Chen and R. Motley
46
BI16
Flu vaccination reaudit
A. Devine, M. Cole and P. Yesudian
BI17
Squamous cell carcinoma of the external auditory meatus in an organ transplant
recipient: management dilemmas in high-risk tumours
A. Lock, J. McGregor and C. Harwood
BI18
Skin cancer and immunosuppression in long-term renal transplant recipients: a
retrospective and case-controlled analysis
R.K.Y. Hung, A. Cronin, I. Rebollo Mesa, S. Frame and E.M. Wain
BI19
Successful treatment of human papilloma virus-induced digital Bowen disease with
a combination of acitretin and topical imiquimod
A. Jamil and T. Desai
BI20
Herpes simplex infection masquerading as actinic keratosis and responding to
topical 5-fluorouracil therapy
P. Gazzani, J. Brockley and A. Ilchyshyn
BI21
Education and awareness of nonmelanoma skin cancer risk in liver transplant
patients
V. Campbell, J. Cash and N. McDougall
BI22
Cutaneous leishmaniasis in an immunocompromised patient
S. Rajan, S. Robinson, J. Pawade and M.G.S. Dunnill
BI23
Sun protection behaviour among those on immunosuppressants
A.E. Honan, L. Burfield, C.P. Harkins, A. Drummond and S. Fraser
BI24
Erythema nodosum, fever and joint pain: azathioprine hypersensitivity reaction in
patients with inflammatory bowel disease
H. Cookson, B. Moriarty, E. Higgins, D. Creamer and S. Walsh
BI25
Sun awareness education and photoprotective behaviour in immunosuppressed
renal disease patients: a questionnaire to assess knowledge and practices
J. Wright and P. Hewins
BI26
Disseminated cutaneous Mycobacterium chelonae and phaeohyphomycosis
N. Meah, S. Hickey, M. Chaponda, L. Forsyth and W. Hope
BI27
Severe cutaneous infection associated with impaired function of myeloid and
lymphoid lineages in haematological malignancy
E. Seccombe, A. Lee, S.S. Vijeratnam, C.Y. Ung, H. Lotery, M. Jenner and M. ArdernJones
BI28
Mycobacterium abscessus presenting with disseminated cutaneous nodules in an
immunosuppressed patient
S. Rasool, T. King and P. Woo
BI29
Destructive cutaneous leishmaniasis in a patient being treated with anti-TNFR. Gurreri, G. Pistone and M.R. Bongiorno
BI30
Sitagliptin for severe psoriasis
M. Lynch, A.-M. Tobin, T. Ahern, D. O’Shea and B. Kirby
The poster viewing session will take place between 13:00 and 13:30 on Thursday 3rd July
NOTES
Thur 3 July
47
Con nuing Professional Development Session
Date:
Time:
Room:
Chair:
Thursday 3rd July
13:30-17:00
Lomond
Dr Graham Sharpe & Dr David Eedy
PROGRAMME
13:30 – 14:15
Arthur Rook Oration – Introduced by Dr David Eedy
The magic and mayhem of skin resident T cells
Dr Rachael Clark (Boston, USA)
14:15 – 14:45
CPD01
14:45 – 15:30
Break
What’s new in Tropical Dermatology
Dr Nick Beeching (Liverpool)
TBC
Guest Lecture – Introduced by Professor Christopher Bunker
The Dark Skin and Photodermatoses
Professor Vinod Sharma (New Delhi, India)
15:30 – 16:00
16:00 – 16:30
CPD02
What’s new in Paediatrics
Dr Nerys Roberts (London)
16:30 – 17:00
CPD03
What’s new in Photodermatology
Dr Sally Ibbotson (Dundee)
Thur 3 July
NOTES
48
Focus Sessions
Date:
Time:
Room:
Chair:
Thursday 3rd July
15:00-15:30
Alsh
Dr Catherine Stefanato
Alopecia Focus Session
PROGRAMME
15:00 – 15:30
Date:
Time:
Room:
Chair:
FS1
Invite speaker: Dr David Fenton, MBE
This interactive session will present, in a vignette-type format, selected encounters with
patients with scarring and non-scarring alopecias.
Diagnostic clues and pitfalls, as well as management pearls will be discussed. Clinicopathological correlation will be emphasised.
Thursday 3rd July
15:00-15:30
Boisdale
Dr Anthony Bewley
‘Itch’ Focus Session
PROGRAMME
15:00 – 15:15
FS21
Diagnosis and treatment of itch in the dermatology clinic
Dr Frances Lawlor
15:15 – 15:30
FS22
The aetiology of itch
Dr Tabi Leslie
Date:
Time:
Room:
Thursday 3rd July
15:00-15:30
Carron
Hyperhidrosis Focus Session
PROGRAMME
15:00 – 15:30
FS3
Top Tips for hyperhidrosis
Dr Niall Wilson
Thur 3 July
NOTES
49
Posters
The posters are situated witihing the exhibition hall. The poster viewing
session will take place during the lunch breaks on Tuesday (even numbered
posters) and Thursday (odd numbered posters). All presenting authors have
been asked to stand by their posters at this time. There will also be an
e-poster display within the exhibiton hall.
P23
Is a randomized controlled trial of intralesional
corticosteroids for alopecia areata currently feasible?
Results of a national clinician survey and observation of
current practice in two U.K. teaching hospitals.
W. Szczecinska, T.W. Siah, J. Brockley, A.R. Shipman, J.M.
Kassim, J. Chalmers, C. Layfield, M. McPhee, H.C. Williams and
A.E. Macbeth
P24
Dermatology trainee doctor survey: acute general medical
on call could endanger patients
R. Coelho and N. Levell
P25
The innovative electronic Teaching Log: a tool to record
teaching and training activity
P. McElnay, D. Howard, D. Bakhbakhi, S. Fowweather and
J. Sansom
P26
Assessment of anxiety and depression associated with
psoriasis in a tertiary referral setting
R. Lamb, M. Turner, F. Matcham, L. Rayner, A. Simpson, M.
Hotopf, J. Barker, C. Smith and K. Jackson
P27
A regional audit on the management of primary cutaneous
squamous cell carcinoma
K.S. Chen and P. Balasubramaniam
P28
Cervical screening uptake in a dermatology patient cohort
on immunosuppressive agents
J. Clowry, I. Callanan, P. Collins, B. Kirby and A. Lally
Clinicopathological Cases
P01
Cutaneous Rosai–Dorfman disease: four diverse clinical
presentations, one unifying histological diagnosis
S.H. Foo, A. Abdullah, A. Rajasekaran, S. Velangi and M.
Maheshwari
P02
A case series of pyoderma gangrenosum after deep inferior
epigastric perforator-flap breast reconstruction
J. Simpson, P. Harris, G. Stamp, S. James, C. Bunker and L.
Fearfield
P03
Use of in vivo reflectance confocal microscopy to monitor
response of an amelanotic lentigo maligna to topical
treatment with imiquimod
A. Alani, M. Sadlier, B. Ramsay and K. Ahmad
P04
Trophic ulceration secondary to carpal tunnel syndrome
J.L.C. Wong, R. Karumanchery, K. Ngan and L. Stewart
P05
Biologics-induced bullous pemphigoid
C. Kiely, M. Connolly, R. Hughes, Q. Razali and A.-M. Tobin
P06
A case of Birt–Hogg–Dubé syndrome
C. Reid and S. Jain
P29
P07
Intravenous human immunoglobulin for treatment of
folliculitis decalvans
N. Ismail, N. Ralph and G. Murphy
A retrospective analysis of patient characteristics in 63
cases of frontal fibrosing alopecia
V.C.Y. Li, P.D. Yesudian and P. Balasubramaniam
P30
P08
An unusual case of scar sarcoidosis
E.D. Owen, J. Collins and P. Hunasehally
Regional audit of the nonsurgical management of basal cell
carcinomas
R.S. Llewellyn and A. Alkali
P09
Topical steroid-induced Cushing syndrome
N. Spierings, T. Stevens and J. Natkunarajah
P31
An audit on emergency dermatology activity
N. Lee and C. Vlachou
P10
Fifty shades of grey: para-phenylenediamine-induced vitiligolike depigmentation
N. Spierings and J. Natkunarajah
P32
Merkel cell carcinoma in Scotland 2000–10
A. Matthews, R. Samuel, A. Affleck, M. Darling, S. Fraser,
G. Gupta, J. Norris, S. Rajpara, J. Vestey and A. Holme
P11
Treatment-resistant nodular prurigo that resolved during
coincidental treatment with a glucagon-like peptide-agonist
R. Hughes, C. Kiely, M. Connolly, J. Gibney and A. Tobin
P33
Impact on dermatology patients of an electronic patient
record
G. Parkins, G. Wylie and J. Leman
P12
Extreme leucocytosis in metastatic melanoma
C. Reid and A. Belgi
P34
P13
Acitretin-induced pyogenic granulomas
N. Spierings, B. Ho and J. Natkunarajah
Review of acute inpatient and general practitioner referrals
to our dermatology department
G. McIntyre, E. Mack, O. Mulholland and S. Hoey
P35
P14
Pancreatic panniculitis with no pancreatic pathology: where
are the ‘ghosts’?
N. Spierings and J. Natkunarajah
Thalidomide use in dermatology: a multitrust regional audit
S. Whitaker, M. Vatve and S. Wahie
General Dermatology
P15
P36
Withdrawn
P37
Skin cancer excision performance in primary and secondary
care in Scotland
W.Y. Haw, S. Fraser, A. Affleck and A. Holme
Male genital lichen sclerosus and filaggrin
T.N. Shim, S.J. Brown, L.E. Campbell, N. Francis,M. Dinneen,D.
Hawkins,A. Muneer, S. Minhas, A. Freeman, W.H.I. McLean and
C.B. Bunker
P38
Commissioning National Health Service dermatology
services: what do patients want?
P. Fiandeiro and K. Ward
The Hidradenitis Suppurativa Priority Setting Partnership
J.R. Ingram, R. Abbott, M. Ghazavi, A. Alexandroff, M. McPhee,
T. Burton and T. Clarke
P39
Subtypes of severe acne vulgaris in a prospective
multicentre study in the U.K.
A.A. Navarini, D. Burden, A. Layton, V. Bataille, S. Walton, C.H.
Smith, J.N. Barker and The Acne Genetic Study Group
P40
Prevalence of metabolic syndrome, insulin resistance and
subatherosclerosis in patients with chronic plaque psoriasis
in India: a hospital-based case–control study
S.K. Kothiwala, N. Khanna, V.K. Sharma, N. Tondon, N. Naik, S.
Sharma and V. Srinivas
P41
Comparison of the clinicoepidemiological profiles of
childhood vitiligo and adult vitiligo: an analysis of 1325 Indian
patients
J. Kaur and A.J. Kanwar
P42
Frontal fibrosing alopecia in premenopausal women: a
review of 16 cases
G. Parkins and S. Holmes
P43
Early clinical and pathological cutaneous features of chronic
graft-versus-host disease
M. Lynch,A. Pagliuca, G. Mufti, J. Salisbury and T. Basu
Sporotrichoid Mycobacterium chelonae
F. Worsnop, P. Mahendran and J. Natkunarajah
Education, Training, Service, Audit
P16
P17
Posters
P18
Methotrexate-responsive oral lichen planus: an analysis of
28 patients
J.C. Steele, V.C.Y. Li, B.P. Rajlawat, E.A.L. Field and P.D.
Yesudian
P19
A retrospective review of a dedicated psychology-based
psychodermatology service
A. Mizara, K. Badsha, M. Griffiths and S. McBride
P20
Clinical utility of virtual patient follow-up in a tertiary
psoriasis service
E. Agius, C. Fleming and C. Smith
P21
Single-centre, retrospective study of patients with psoriasis
referred to a psychology-based psychodermatology service
S. Aguilar-Duran, A. Mizara, J. Champagne, K. Badsha, M.
Griffiths and S.R. McBride
P22
What are the real influences on dermatology outpatient
discharge decisions?
N.A. Harun, A.Y. Finlay, V. Piguet and S. Salek
50
P44
How people with acne decide whether their treatment is
working
K. Warburton,H. Whitehouse, R. El-Naes, A. Eady and A. Layton
P45
Persistence of viable Mycobacterium leprae after multidrug
therapy in patients with multibacillary leprosy. Is this the
missing link in leprosy eradication?
T. Narang, S. Dogra and U.N. Saikia
P46
Management of morphoea: results of a national survey of
U.K. clinicians
K.L. Warburton,M.J. McPhee, L.J. Savage, A.E. Honan,
R. Montgomery, M. Ghazavi, D. Torley, K. Shams and J.R.
Ingram
P47
Self-improving collodion baby: the dynamic stratum corneum
K. Muttardi, F.M. Tatnall, M. Murdoch A.E. Martinez and K. Batta
P48
Connexin 30 mutations can lead to a clinical phenotype
resembling pachyonychia congenita
G. Hale,N. Wilson, F. Smith, M. Schwartz and M. Zamiri
P49
Young patients with complicated perianal and peristomal
predicaments
Z.Z.N. Yiu, F.R. Aliand C.C. Lyon
P50
Leprosy: is it being misdiagnosed?
F. Ali, A.A. Atwan, J. Vyas and V. Piguet
P51
Enhanced expression of interleukin (IL)-17, IL-10 and IL-1 in
hidradenitis suppurativa
G. Kelly,C. Sweeney,R. Fitzgerald, A. Lally,A.-M. Tobin and B.
Kirby
P52
Plasma cell vulvitis: a series of eight cases
G. Dawn,D. Caruana,V. Harper and F. Gallagher
P53
Neoscytalidium dimidiatum: a tropical mould of mankind and
mangoes
J. Powell and J. Gach
P54
A clinical and molecular analysis of scalp folliculitis and
folliculitis decalvans
A. Lee, S.-Y. Cho, T.-S. Yam and M. Ardern-Jones
P55
Cutaneous manifestations of leucocyte adhesion
deficiency-1
R. Sarangal, S. Dogra and A.J. Kanwar
P56
A pilot study comparing the impact of acne on the quality of
life of women with persistent acne vs. late-onset acne
S. Ladbrooke, M. Waterman, R. El-Naes, C. Finch, E. Fryatt,
V. Allgar, A. Eady and A. Layton
P57
Delusional infestation carries mortality: a report of two cases
S. Nasir, A. Ahmed, L. Holloway, R. Meyrick-Thomas and A.
Bewley
P58
Cutaneous side-effects of antihepatitis C treatment: the U.K.
experience
E. Orrin, K. Agarwal, A. Barnabas and S. Walsh
P59
A systematic review of the management and outcome of
toxic epidermal necrolysis treated in burns centres
P. Mahar, J. Wasiak, B. Hii, H. Cleland, D. Watters, D. Gin and
A. Spinks
P60
Factors associated with hair loss in women of African descent
living in London, U.K.: findings of a cross-sectional study
O.E. Dadzieand A. Salam
P61
Pyoderma gangrenosum: clinical features concealed by
vacuum-associated closure
R. Hellen, L. Jennings and S. Collins
P62
New missense mutation in the fumarate hydratase gene
associated with hereditary leiomyomatosis and renal cell
cancer syndrome
N. Bansal,A. Cuthbert, E. Woodward and M. Kaur
P67
National survey of patients with hereditary basal cell naevus
syndrome: psychological impact, treatment and care
F.R. Ali,N.J. Collier,G. Evans, M. Costello, S. Webster and J.T.
Lear
P68
Treatment of extensive eyelid basal cell carcinoma with
vismodegib as an alternative to Mohs micrographic surgery
L. Wujanto,D. Basak, A. Milligan,G. Stewart and E. Seaton
P69
Are general practitioners in areas of higher skin cancer
incidence better at diagnosing skin cancer?
D. Keith,A. Ives, T. Jones, D. de Berkerand J. Verne
P70
Nail unit squamous cell carcinoma in people with immune
suppression
E. Ormerod and D. de Berker
P71
Two cases of mycosis fungoides palmaris et plantaris
A. Matthews,S. Holmes,B. Jackson and D. Bilsland
Therapy
Isotretinoin and peanut allergy: what’s all the fuss about?
N. Spierings, J. Natkunarajah, A. Bansal and L. Ostlere
P73
Cognitive behavioural therapy for two patients with
delusional infestation: a new concept with a positive
outcome
R. Shah, A. Ahmed and A. Bewley
P74
Cutaneous adverse reactions to tyrosine kinase inhibitors in
a cohort of patients treated for chronic myeloid leukaemia
A. Sears, E. Orrin, J. Salisbury, G. Mufti, H. De Lavallade and
T. Basu
P75
Retrospective study on the effect of conventional therapy,
antitumour necrosis factor agents and ustekinumab on
weight, body mass index and waist circumference in patients
with chronic plaque psoriasis
L. Patricia, S. Gupta, M. Clement and K. Watson
P76
Clinical outcomes of patients receiving topical treatments
for pyoderma gangrenosum: a prospective observational
study
F. Craig, N. Greenlaw, E. Harrison, J. Mason, E. Mitchell, J.
Norrie, A. Ormerod, K. Thomas, H. Williams and Stop Gap Trial
Group Collaborators
P77
Safety of systemic therapies for psoriasis on reproductive
potential and outcomes
Z.Z.N. Yiu, R.B. Warren and C.E.M. Griffiths
P78
Efficacy of photodynamic therapy for treatment of basal cell
carcinoma in the elderly
N. Collier, F. Ali and J. Lear
P79
Noncultured epidermal cell suspension and dermal fat
grafting in a single sitting for the reconstruction of an
irregular, atrophic and depigmented forehead scar: an
innovative approach
R. Sarangal, S. Dogra, S. Yadav and A. Sakral
P80
Withdrawn
P81
Daptomycin for the treatment of diabetic foot infections:
6-year clinical experience from the EU-CORESM registry
A. Gonzalez-Ruiz, S. Hedderwick, M. Allen, A. Tamta, C.
Andrews and R.A. Seaton
P82
Efficacy and safety of intralesional Mycobacterium w vaccine
and cryotherapy in the treatment of refractory extragenital
warts: a randomized open-label comparative study
S. Dogra, A. Kumar and A.J. Kanwar
P83
Acute systemic sarcoidosis complicating ustekinumab
therapy for chronic plaque psoriasis
J. Powell, F. Woodhead, P. Perkins, N. Brearley and J. Gach
P84
Alpha-1-antitrypsin deficiency panniculitis treated with
enzyme replacement
S. Rasool, K. Harman, M. Bamford and G. Saldanha
P85
Rivaroxaban: a novel treatment for livedoid vasculopathy
T. Tull, B. Hunt and R. Groves
P86
The effect of a complex emollient cream containing 5%
urea, ceramide 3 and lactic acid, compared with a simple
emollient, on the skin barrier in older people with dry skin
S. Danby, K. Brown, T. Higgs-Bayliss, J. Chittock and M. Cork
Skin Cancer
P63
Stage I mycosis fungoides: frequent association with a
favourable prognosis but disease progression and diseasespecific mortality may occur
A. Wernham, F. Shah, R. Amel-Kashipaz, M. Cobbold and
J. Scarisbrick
P64
Cables1, male genital lichen sclerosus and penile cancer
T.N. Shim, N. Francis, D. Peston, S. Phan, S. Minhas, A. Muneer,
M. Dinneen, A. Freeman and C.B. Bunker
P65
Experience of management of Sézary syndrome in a regional
cutaneous T-cell lymphoma centre
P. Laws, R. Alhusayen and N. Shear
P66
Rates of recurrence and metastases of high-risk cutaneous
squamous cell carcinoma: a 5-year single-institution study
P. Subramanian, B. McDonald and F. Ismail
51
Posters
P72
Hot Topics
This is a new ini a ve for the 94th Annual Mee ng. They will be semi-informal set-up taking place is two designated areas within the Exhibi on
Hall 5 during breaks. These are highlighted as HT1 and HT2 on the exhibi on plan.
TUESDAY 1st JULY – morning break
10:45 – 11:15
HT1
Urticaria - what is new?
Dr Tabi Leslie
10:45 – 11:15
HT2
Reasons for our New Clinical Classification of Onychomycosis
Dr Robert Baran
TUESDAY 1st JULY – a ernoon break
15:45 – 16:15
HT1
Hot historical Dermatologists: who was the greatest?
A story of baldness and facial hair
Dr Nick Levell
15:45 – 16:15
HT2
Drug Rashes
Dr Mike Ardern-Jones & Dr Sarah Walsh
WEDNESDAY 2nd JULY – a ernoon break
16:15 – 16:45
HT1
HPV vaccination for men
Dr Bill Porter
16:15 – 16:45
HT2
Changes in Primary & Secondary Interface with new commissioning
Dr Stephen Kownacki
THURSDAY 3rd JULY – morning break
10:30 – 11:00
HT1
Outcome Measures for Dermatology Clinical Trials
Prof Kim Thomas & Dr Joanne Chalmers
10:30 – 11:00
HT2
What's hot in psychodermatology
Dr Anthony Bewley & Dr Andrew Affleck
52
Exhibi on Plan
53
OA
D
KELVINHALL
P
P
A
P
C
OS
SR
OA
D
RE
V
T
PA
R
SS
IDE
STV
LYD
E
R OA D
VIN
EL
EET
TE
R
EX
GO
VA
N
RO
AD
E
YD
CL
WA
Y
C
AR
ESS
7
2
PR
EXHIBITION
CENTRE
STATION
EE
T
TR
ES
AR
GY
L
P
RK
PA
PARK
CIRCUS
ET
N
RO
AD
ET
RE
ST
TE
R
H ST R
EET
LYN
CE
WOODSIDE PLA
WOODSIDE TERRACE
DOCH STREET
L AN
DE
P
SPRING
F
R CLY
LD QU
AY
R IV E
C E FI E
W
IELD
QUAY
P
ON
Glasgow
Airport
8 miles
A N DE R S
T
EE
TR
ES
AR
GY
L
BALACLAVA ST
Glasgow
Prestwick
Airport
30 miles
QUAY
P
15
WEST
P
REGE
PAISLEY ROAD
RIVER CLYDE
P
18
AW
ARGYLE
M8
WEST
10
STREET
T
20
P
NT
ET
14
17
REET
STREET
ST
P
T
HO
WA
R
TR
EE
ES
ET
CL
YD
STR
E
ET
DS
T
10
T RE E
P
ARGYLE ST
O SB
ORNE STATION
STR
ST ENOCH
E
A
ST EN RGYLE STR
EET
CENTROCH
E
P
P
GEOR
SQUA GE
RE
QUEEN ST
STATION
PLAC
E
RO
EXCH YAL
AN
SQUA GE
RE
ET
BATH ST
RE
EET
T STR
BUCH
A
GALLERNAN
IES
ORGE
KY
P
GEOR
GE ST
WILSO
N ST
STREE
T
T
EGATE
BRIDG
P
TRON
GATE
REE
P
INGRAM
REET
P
COCH
RAN
E ST
P
REET
CATHE
DRA L STREET
LE
ET
RE
ST
P
P
19
P
M8
P
BLA
CKF
RIAR
S
P
BEL
L
ST
LO
ND
ON
P
ET
P
P
CASTLE STREET
P
P
P
EE T
STR
GH
HI
DUK
E ST
REE
T
P
HIGH STREET STATION
P
LLO
WGAT P
E
RO
AD
GA
ST
RE
ST
ROTTEN
ROW EA
ST
BAIRD STREET
M8
07 Hilton Garden Inn
08 Hilton Glasgow
09 Holiday Inn Glasgow Theatreland
10 Holiday Inn Express Riverside
11 Hotel Du Vin at One
Devonshire Gardens
12 Ibis Hotel
13 Indigo Hotel
14 Jury’s Inn Hotel
15 Menzies
16 Novotel
17 Park Inn By Radisson
18 Premier Inn Argyle Street
19 Premier Inn George Square
20 Radisson Blu
BUCHANAN BUS STATION
KILLE
RMON
CENT
PRINCE
SQUA S
RE
ARGYL
L
M8
COW
CADD
ENS R
OAD
BUCHANAN
STREET
W GE
ST VIN
9
4
P
DOBBIES LOAN
SOUTH PORTLAND ST
FOOTBRIDGE
P
HO
WA
RD
P
GOR
G
RDON
CENTRAL
STATION
P
6
REET
STRE
E
T
ET
LL ST
ROA
D
T
ENS
TREE
STRE
IEHA
BATH
SAUC
H
GE ST
STRE
C OW
CAD
D
RENF
REW
S
REGE
GEOR
WEST
P
P
P
COWCADDENS
M8
01 Blythswood Hotel
02 Campanile
03 Crowne Plaza
04 Express by Holiday Inn Theatreland
05 Glasgow Marriott
06 Grand Central
HOTELS
A SECC
B Kelvingrove Art Gallery
C Glasgow Science Centre
D Brian Maule at Chardon d’Or
VENUES
ST VIN
CENT
E PLA
CE
CLYD
D
EET
TRADESTON
BRIDGE
MIEL
BROO
1
O STR
13
ET
STRE
WATER
LO
P
T
BLYTHS
WOOD
SQ
WELL
BOTH
ET
STRE
T
STREE
TREE
NT S
BAT
A HS
TREE
T
12 16
16
CRIMEA ST
EET
ARGYL
LE
E STR
5
ET
STRE
ANDERSTON
STATION
8
P
CENT
ST VIN
P
ELMBANK CRE
S.
T
TREE
REET
EW ST
ALL S
HIEH
SAUC
ET
STRE
H
LEUC
P
AM
GRAH
BUCC
WEST
HILL
RENFR
M8
ST GEORGE’S
CROSS
CHARING CROSS STATION
k
walk
10 mins w
nt
entre
ccentre
to the city cen
ST VINCENT STREET
KENT ROAD
CLYDESIDE EXPRESSWAY
O RT
P
BERKELEY STREET
HO
UL
DS
W
S
NC
E
RI
EA
TW
ES
mins by
0m
blic transport
public
he ccity centre
tto the
TP
WE
S
GR
KELVINBRIDGE
HALL STRE
SAUCHIE
ROYAL TERRACE
KELVINGROVE
PARK
KG
RO
VE
CLY
DE
S
SECC
REET
RIV
ER
C
PACI
FIC
DRI
VE
BELL’S
BRIDGE
BBC
SCOTLAND
3
RI
EE
TR
LS
SCOTTISH EXHIBITION
& CONFERENCE CENTRE
A
E
AL
EH
HI
AVEN
U
ET
TRE
ON
S
GIB
S
T
GH ST
NHAU
KELVI
AD
RO
TR
EE
T
UC
SA
S IT Y
CLYDE
SIDE
EXP
RES
STO SWA
Y
BC
R
H
UG
HA
B
EE
STR
ES
ET
ST
MILLENNIUM
BRIDGE
P
ET
T STRE
GILBER
AD
RO
RIVER KELV
IN
UNIV
ER
RG
KE
R
EO
EA
TG
TRE
ET
E
P
GR
SLA
ND
SA
LT
OU
DUMBART
ON R
OA
D
SANDYF
ORD ST
DS
RE
TON LAN
E
ASH
UNIVERSITY PLAC
SR
RE
BY
BU
NH
OU
SE
STR
NK
BA
N
STREET
YORKHILL
HIL
AY
GR
RO
AD
EA
LH
WA
Y
LVIN
ET
LV
IN
ER
BY
S
T
RE
ET
GROVE
STRE
ET
KE
S
TR
E
ER
KE
D
K
RIV
ER
KELV
IN
G
ST
M8
M8
11
ET
REET
RO
XBU
RG
HS
T
FINNIEST
ON STRE
GARNET ST
RO
AD
STREET
FINNIE
STON
GE
’S
RO
AD
WASHINGTON STREET
T
ET
EO
R
M8
EL M B
A N K S TR
EET
MCALPINE STR
EET
LAN
D ST
PITT
CARRICK ST
REET
HOL
STRE
ET
ST
PITT
LAS ST
DOUG
BROWN STR
EET
ET
EET
SCOTT
STR
STRE
ET
LAS
STRE
HOPE
STRE
USIE
H
ET
ELL
DALH
O
SWOO
D STR
EET
STRE
WEST
STR
ROSE
CAMP
B
WE
ET
ANAN
R STR
STRE
ET
HOPE S
TREE
T
BLYT
YORK STREET
WEST
STRE
ET
EET
LLING
TON S
TR
ROBERTSON STREET
NORT
ET
EET
RENF
IEL
IE
LD STR
MITCHELL ST
STRE
ET
STRE
BUCH
EET
ET
EET
DOUG
STREET
ET
JAMES WATT
EET
Y
STR
VA
TO
R
N STR
QUEE
NILE
STRE
ANAN
BUCH
ST EN
SQUAROCH
E
T
ET
CAMB
RIDGE
OSWALD STREET
KING GEORGE V BR
UNION STREET
JA
AMAIC
A STR
E
GE
GOW
TREE
ER S
MILL
EET
NOVE
H HA
H FR
NORT
HOPE
BRID
GLAS
REET
LL ST
KWE
STOC
EET
T
ICK S
EDER
N
HESO
HUTC
T
FORD
STRE
ET
BRUNSW
ICK
STREE
GLASS
STRE
JOHN
STREET
EET
STR
KING
TROS
E STR
MON
D
IGGS
SS W YN
LER
CR O
CAN
D
54
ST
OB
T
ET
RE
ST
C O NG
KE
CLIFTON STREET
STREET
AR
ELDERSLIE
LTM
GRANVILLE ST
ARCADE
SA
E
YL
RG
OODSIDE CRES
STREET
A
AN
NEWTON
WAL
L ST
NORTH STREET
LBIO
N
DL
ET
OO
W
RE
RD
AD
NDAS RO
PORT DU
ST
ON
HT
DS
AD
RO
AN
LO
GH
ES
BI
HI
AS
B
DO
COLLINS
ER
Map of Glasgow
T
SS
EW
DR
AN
ST
© GLASGOW CITY MARKETING BUREAU 2014
General Informa on
DELEGATE BAGS
The Conference & Events Department is aiming to limit the impact the Annual
Mee ng has upon the environment.
Conferences and exhibi ons provide a huge amount of waste and this year we aim to
con nue to implement measures to improve this.
Following feedback from previous mee ngs delegates will be provided with a generic
delegate bag (as illustrated). This bag is made from recycled plas c bo le and has the
BAD Logo on the side.
We have made a decision not to include a sponsor, date or annual mee ng des na on.
This will enable you to reuse the bag for other annual mee ngs as well as other BAD
mee ngs. We hope this will become your BAD ‘Bag for Life’.
Don’t forget your bag!
If you have a bag from a previous annual mee ngs please bring it with you
EVALUATION FORM
This year’s evalua on form will be on-line and all a endees will be sent a link a er the mee ng.
Thank you in advance for taking the me to complete it, as it is an invaluable tool for us in organising future mee ngs.
CES MEETINGS CALENDAR
June 2014
November 2014
Thesis / BAD / BSID Research Course
Venue: Willan House, London
Date: 12th – 13th June
SpR Training Event
Venue: Indian YMCA, London
Date: 13th – 14th November
September 2014
BCDG Annual Mee ng
Venue: Willan House, London
Date: 15th November
XV World Congress on Cancers of the Skin
Venue: EICC, Edinburgh
Date: 3rd – 6th September
Dermdoc
Venue: Willan, London
Date: 29th September
October 2014
Clinical Dermatology Update
Mee ng for Staff and Associate Specialist Doctors
Venue: Coombe Abbey, Coventry
Date: 1st – 3rd October
The Annual UK Dermatology Course for Consultants
Venue: Hilton Paddington Hotel, London
Date: 21st – 22nd November
December 2014
7th Interna onal Congress, Psoriasis from
Gene to Clinic 2014
Venue: QEIICC, London
Date: 11th – 13th December
For Further Details on any of these mee ngs please contact:
Conference & Event Services, 4 Fitzroy Square, London W1T 5HQ
Email: conference@bad.org.uk Tel: + (0)20 7391 6358
Join our facebook Group
follow us on Twi er
55
NOTES
56
IT TAKES
SEVEN
SKIN CANCER APPEAL
HELP US
LEAD THE
FIGHT AGAINST
SKIN CANCER
‘IT TAKES 7’ IS A FUNDRAISING CAMPAIGN BY THE BRITISH SKIN
FOUNDATION TO RAISE MONEY FOR VITAL RESEARCH INTO SKIN CANCER
VISIT WWW.ITTAKESSEVEN.ORG.UK TO GET
INVOLVED AND PLEASE HELP US SPREAD THE WORD
57
Coming Soon….
www.bad2014app.org
• 
• 
• 
• 
• 
Review agenda & speakers
Interactive floorplans
View abstracts & e-posters
View sponsors & exhibitors
Select sessions to record your own CPD
BAD are grateful to Janssen
for their support
of the meeting app
58
15th World Congress on Cancers of the Skin
3-6 September 2014
Edinburgh, Scotland
visit
www.wccs2014.org
for details